| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | COL4A1 RELN FN1 TNC LAMA2 LAMA3 PAPLN TECTA SSPOP FBLN2 IGFBP7 LTBP1 LTBP2 MUC5AC FBN3 | 6.12e-14 | 188 | 105 | 15 | GO:0005201 |
| GeneOntologyMolecularFunction | calcium ion binding | STAB2 DSC1 DGKB TENM2 F10 SVEP1 STAB1 NELL1 CELSR1 FBLN2 EGF CELSR2 ANKEF1 JAG1 LRP2 DLK2 ADGRE5 LTBP1 LTBP2 LTBP3 FBN3 NOTCH2 NOTCH3 | 5.54e-12 | 749 | 105 | 23 | GO:0005509 |
| GeneOntologyMolecularFunction | integrin binding | 3.63e-07 | 175 | 105 | 9 | GO:0005178 | |
| GeneOntologyMolecularFunction | structural molecule activity | COL4A1 RELN RAPSN FN1 TNC LAMA2 LAMA3 PAPLN TECTA SSPOP ACTL7A FBLN2 IGFBP7 JAG1 LTBP1 LTBP2 MUC5AC FBN3 | 8.52e-07 | 891 | 105 | 18 | GO:0005198 |
| GeneOntologyMolecularFunction | growth factor binding | 1.70e-06 | 156 | 105 | 8 | GO:0019838 | |
| GeneOntologyMolecularFunction | extracellular matrix binding | 2.34e-06 | 73 | 105 | 6 | GO:0050840 | |
| GeneOntologyMolecularFunction | glycosaminoglycan binding | 1.21e-05 | 268 | 105 | 9 | GO:0005539 | |
| GeneOntologyMolecularFunction | cell adhesion molecule binding | FN1 TNC ADAMTS5 ADAM10 ITGB2 ITGB3 TENM2 ITGB5 SVEP1 CCN4 TENM4 TENM3 NOTCH3 | 1.56e-05 | 599 | 105 | 13 | GO:0050839 |
| GeneOntologyMolecularFunction | low-density lipoprotein particle receptor activity | 7.53e-05 | 16 | 105 | 3 | GO:0005041 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on carbon-sulfur bonds | 8.19e-05 | 3 | 105 | 2 | GO:0046508 | |
| GeneOntologyMolecularFunction | adenosylhomocysteinase activity | 8.19e-05 | 3 | 105 | 2 | GO:0004013 | |
| GeneOntologyMolecularFunction | cargo receptor activity | 8.58e-05 | 85 | 105 | 5 | GO:0038024 | |
| GeneOntologyMolecularFunction | insulin-like growth factor binding | 1.29e-04 | 19 | 105 | 3 | GO:0005520 | |
| GeneOntologyMolecularFunction | lipoprotein particle receptor activity | 1.75e-04 | 21 | 105 | 3 | GO:0030228 | |
| GeneOntologyMolecularFunction | transforming growth factor beta binding | 3.36e-04 | 26 | 105 | 3 | GO:0050431 | |
| GeneOntologyMolecularFunction | Notch binding | 3.77e-04 | 27 | 105 | 3 | GO:0005112 | |
| GeneOntologyMolecularFunction | scavenger receptor activity | 3.77e-04 | 27 | 105 | 3 | GO:0005044 | |
| GeneOntologyMolecularFunction | microfibril binding | 4.05e-04 | 6 | 105 | 2 | GO:0050436 | |
| GeneOntologyMolecularFunction | peptidase regulator activity | 4.20e-04 | 257 | 105 | 7 | GO:0061134 | |
| GeneOntologyMolecularFunction | metalloendopeptidase activity | 4.31e-04 | 120 | 105 | 5 | GO:0004222 | |
| GeneOntologyMolecularFunction | peptidase inhibitor activity | 4.65e-04 | 187 | 105 | 6 | GO:0030414 | |
| GeneOntologyMolecularFunction | heparin binding | 5.35e-04 | 192 | 105 | 6 | GO:0008201 | |
| GeneOntologyMolecularFunction | polysaccharide binding | 5.71e-04 | 31 | 105 | 3 | GO:0030247 | |
| GeneOntologyMolecularFunction | sulfur compound binding | 1.60e-03 | 323 | 105 | 7 | GO:1901681 | |
| GeneOntologyMolecularFunction | insulin-like growth factor I binding | 2.06e-03 | 13 | 105 | 2 | GO:0031994 | |
| GeneOntologyMolecularFunction | ionotropic glutamate receptor binding | 2.59e-03 | 52 | 105 | 3 | GO:0035255 | |
| GeneOntologyMolecularFunction | endopeptidase inhibitor activity | 2.63e-03 | 180 | 105 | 5 | GO:0004866 | |
| GeneOntologyMolecularFunction | low-density lipoprotein particle binding | 3.97e-03 | 18 | 105 | 2 | GO:0030169 | |
| GeneOntologyMolecularFunction | metallopeptidase activity | 4.12e-03 | 200 | 105 | 5 | GO:0008237 | |
| GeneOntologyMolecularFunction | endopeptidase regulator activity | 4.21e-03 | 201 | 105 | 5 | GO:0061135 | |
| GeneOntologyMolecularFunction | protein kinase C binding | 5.09e-03 | 66 | 105 | 3 | GO:0005080 | |
| GeneOntologyBiologicalProcess | vasculature development | COL4A1 SPRY2 STAB2 FN1 SPINT1 ADAM10 ITGB2 ITGB3 SVEP1 STAB1 EGF ADAMTS9 JAG1 LRP2 LTBP1 C6 RECK NOTCH2 NOTCH3 | 3.34e-07 | 969 | 104 | 19 | GO:0001944 |
| GeneOntologyBiologicalProcess | extracellular matrix organization | COL4A1 FN1 ADAMTS3 SPINT1 LAMA2 PAPLN ADAMTS5 ADAM10 ITGB3 ADAMTS9 ADAMTS20 RECK | 4.45e-07 | 377 | 104 | 12 | GO:0030198 |
| GeneOntologyBiologicalProcess | extracellular structure organization | COL4A1 FN1 ADAMTS3 SPINT1 LAMA2 PAPLN ADAMTS5 ADAM10 ITGB3 ADAMTS9 ADAMTS20 RECK | 4.58e-07 | 378 | 104 | 12 | GO:0043062 |
| GeneOntologyBiologicalProcess | external encapsulating structure organization | COL4A1 FN1 ADAMTS3 SPINT1 LAMA2 PAPLN ADAMTS5 ADAM10 ITGB3 ADAMTS9 ADAMTS20 RECK | 4.71e-07 | 379 | 104 | 12 | GO:0045229 |
| GeneOntologyBiologicalProcess | circulatory system development | COL4A1 SPRY2 STAB2 FN1 SPINT1 ADAMTS5 ADAM10 ITGB2 ITGB3 SVEP1 STAB1 CCN4 TENM4 EGF ADAMTS9 JAG1 LRP2 LTBP1 C6 RECK NOTCH2 NOTCH3 ADAP2 | 6.28e-07 | 1442 | 104 | 23 | GO:0072359 |
| GeneOntologyBiologicalProcess | anatomical structure formation involved in morphogenesis | COL4A1 SPRY2 RELN STAB2 FN1 SPINT1 ADAMTS5 ITGB2 ITGB3 STAB1 ACTL7A CELSR1 TENM4 EGF ADAMTS9 JAG1 LRP2 C6 ERVS71-1 ERVPABLB-1 RECK NOTCH2 NOTCH3 | 1.02e-06 | 1483 | 104 | 23 | GO:0048646 |
| GeneOntologyBiologicalProcess | tube morphogenesis | COL4A1 SPRY2 STAB2 FN1 SPINT1 TNC ITGB2 ITGB3 STAB1 CELSR1 EGF ADAMTS9 JAG1 LRP2 C6 CSMD1 RECK NOTCH2 NOTCH3 | 3.09e-06 | 1125 | 104 | 19 | GO:0035239 |
| GeneOntologyBiologicalProcess | integrin-mediated signaling pathway | 3.14e-06 | 124 | 104 | 7 | GO:0007229 | |
| GeneOntologyBiologicalProcess | blood vessel development | COL4A1 SPRY2 STAB2 FN1 SPINT1 ITGB2 ITGB3 STAB1 EGF ADAMTS9 JAG1 LRP2 LTBP1 C6 RECK NOTCH2 NOTCH3 | 3.82e-06 | 929 | 104 | 17 | GO:0001568 |
| GeneOntologyBiologicalProcess | angiogenesis | COL4A1 SPRY2 STAB2 FN1 ITGB2 ITGB3 STAB1 EGF ADAMTS9 JAG1 C6 RECK NOTCH2 NOTCH3 | 1.27e-05 | 708 | 104 | 14 | GO:0001525 |
| GeneOntologyBiologicalProcess | blood vessel morphogenesis | COL4A1 SPRY2 STAB2 FN1 ITGB2 ITGB3 STAB1 EGF ADAMTS9 JAG1 LRP2 C6 RECK NOTCH2 NOTCH3 | 1.46e-05 | 817 | 104 | 15 | GO:0048514 |
| GeneOntologyBiologicalProcess | tube development | COL4A1 SPRY2 STAB2 FN1 SPINT1 TNC ITGB2 ITGB3 STAB1 CELSR1 EGF ADAMTS9 JAG1 LRP2 LTBP3 C6 CSMD1 RECK NOTCH2 NOTCH3 | 2.01e-05 | 1402 | 104 | 20 | GO:0035295 |
| GeneOntologyBiologicalProcess | motor neuron migration | 5.42e-05 | 15 | 104 | 3 | GO:0097475 | |
| GeneOntologyBiologicalProcess | morphogenesis of an epithelium | COL4A1 SPRY2 SPINT1 TNC ITGB3 ITGB5 CELSR1 EGF JAG1 LRP2 CSMD1 NOTCH2 | 6.70e-05 | 619 | 104 | 12 | GO:0002009 |
| GeneOntologyBiologicalProcess | cell-matrix adhesion | 6.77e-05 | 270 | 104 | 8 | GO:0007160 | |
| GeneOntologyBiologicalProcess | transforming growth factor beta receptor superfamily signaling pathway | 8.46e-05 | 445 | 104 | 10 | GO:0141091 | |
| GeneOntologyBiologicalProcess | Notch signaling pathway | 9.46e-05 | 210 | 104 | 7 | GO:0007219 | |
| GeneOntologyBiologicalProcess | axon guidance | 9.86e-05 | 285 | 104 | 8 | GO:0007411 | |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | RELN FN1 LAMA2 LAMA3 TECTA TTC3 ADAM10 TENM2 CELSR2 SEMA5B LRP2 NOTCH2 NOTCH3 | 9.90e-05 | 748 | 104 | 13 | GO:0048667 |
| GeneOntologyBiologicalProcess | neuron projection guidance | 1.01e-04 | 286 | 104 | 8 | GO:0097485 | |
| GeneOntologyBiologicalProcess | tissue morphogenesis | COL4A1 SPRY2 SPINT1 TNC ADAMTS5 ITGB3 ITGB5 CELSR1 EGF JAG1 LRP2 CSMD1 NOTCH2 | 1.02e-04 | 750 | 104 | 13 | GO:0048729 |
| GeneOntologyBiologicalProcess | cell junction organization | COL4A1 RELN RAPSN FN1 TNC LAMA3 DGKB ADAM10 ITGB3 SVEP1 TENM4 TENM3 CNTNAP4 CHRDL1 ADGRE5 | 1.08e-04 | 974 | 104 | 15 | GO:0034330 |
| GeneOntologyBiologicalProcess | regulation of anatomical structure morphogenesis | SPRY2 RELN FN1 TTC3 ADAM10 ITGB2 ITGB3 STAB1 RHOQ CELSR1 TENM4 EGF ADAMTS9 JAG1 C6 RECK | 1.09e-04 | 1090 | 104 | 16 | GO:0022603 |
| GeneOntologyBiologicalProcess | pulmonary valve morphogenesis | 1.33e-04 | 20 | 104 | 3 | GO:0003184 | |
| GeneOntologyBiologicalProcess | response to growth factor | SPRY2 ADAMTS3 SPINT1 TNC XIAP ITGB3 ITGB5 LRP2 CHRDL1 LTBP1 LTBP2 LTBP3 FUT8 NOTCH2 | 1.39e-04 | 883 | 104 | 14 | GO:0070848 |
| GeneOntologyBiologicalProcess | cell surface receptor protein serine/threonine kinase signaling pathway | 1.62e-04 | 482 | 104 | 10 | GO:0007178 | |
| GeneOntologyBiologicalProcess | synapse organization | COL4A1 RELN RAPSN TNC DGKB ADAM10 ITGB3 TENM4 TENM3 CNTNAP4 CHRDL1 ADGRE5 | 1.73e-04 | 685 | 104 | 12 | GO:0050808 |
| GeneOntologyBiologicalProcess | morphogenesis of a branching epithelium | 1.95e-04 | 236 | 104 | 7 | GO:0061138 | |
| GeneOntologyBiologicalProcess | cell-substrate adhesion | 2.31e-04 | 410 | 104 | 9 | GO:0031589 | |
| GeneOntologyBiologicalProcess | pulmonary valve development | 2.33e-04 | 24 | 104 | 3 | GO:0003177 | |
| GeneOntologyBiologicalProcess | positive regulation of melanocyte differentiation | 2.49e-04 | 5 | 104 | 2 | GO:0045636 | |
| GeneOntologyBiologicalProcess | cell projection morphogenesis | RELN FN1 LAMA2 LAMA3 TTC3 ADAM10 ITGB3 TENM2 CELSR2 SEMA5B LRP2 NOTCH2 NOTCH3 | 2.62e-04 | 826 | 104 | 13 | GO:0048858 |
| GeneOntologyBiologicalProcess | epithelial tube morphogenesis | 2.81e-04 | 421 | 104 | 9 | GO:0060562 | |
| GeneOntologyBiologicalProcess | embryo development | SPRY2 FN1 ADAMTS3 SPINT1 LAMA2 LAMA3 TECTA ADAM10 TDRD7 CELSR1 TENM4 JAG1 LRP2 CHRDL1 C6 FUT8 RECK NOTCH2 | 2.85e-04 | 1437 | 104 | 18 | GO:0009790 |
| GeneOntologyBiologicalProcess | enzyme-linked receptor protein signaling pathway | COL4A1 SPRY2 ADAMTS3 XIAP ITGB3 ITGB5 SVEP1 RHOQ EGF LRP2 CHRDL1 LTBP1 LTBP2 LTBP3 FUT8 NOTCH2 | 2.86e-04 | 1186 | 104 | 16 | GO:0007167 |
| GeneOntologyBiologicalProcess | heart valve morphogenesis | 2.89e-04 | 63 | 104 | 4 | GO:0003179 | |
| GeneOntologyBiologicalProcess | cell morphogenesis | RELN FN1 LAMA2 LAMA3 TECTA TTC3 ADAM10 ITGB2 ITGB3 TENM2 RHOQ CELSR2 SEMA5B LRP2 NOTCH2 NOTCH3 | 3.08e-04 | 1194 | 104 | 16 | GO:0000902 |
| GeneOntologyBiologicalProcess | sensory organ development | COL4A1 SPRY2 TECTA ADAM10 TDRD7 CELSR1 IGFBP7 TENM3 ADAMTS9 JAG1 CHRDL1 NOTCH2 | 3.10e-04 | 730 | 104 | 12 | GO:0007423 |
| GeneOntologyBiologicalProcess | cell-cell adhesion | FLOT2 ZAN DSC1 LAMA3 ITGB2 ITGB3 TENM2 ITGB5 SVEP1 CELSR1 TENM4 CELSR2 TENM3 JAG1 MEGF10 | 3.22e-04 | 1077 | 104 | 15 | GO:0098609 |
| GeneOntologyBiologicalProcess | morphogenesis of a branching structure | 3.34e-04 | 258 | 104 | 7 | GO:0001763 | |
| GeneOntologyBiologicalProcess | cellular response to growth factor stimulus | SPRY2 ADAMTS3 SPINT1 XIAP ITGB3 ITGB5 LRP2 CHRDL1 LTBP1 LTBP2 LTBP3 FUT8 NOTCH2 | 3.45e-04 | 850 | 104 | 13 | GO:0071363 |
| GeneOntologyBiologicalProcess | sensory organ morphogenesis | 3.47e-04 | 343 | 104 | 8 | GO:0090596 | |
| GeneOntologyBiologicalProcess | glomerulus vasculature morphogenesis | 3.73e-04 | 6 | 104 | 2 | GO:0072103 | |
| GeneOntologyBiologicalProcess | glomerular capillary formation | 3.73e-04 | 6 | 104 | 2 | GO:0072104 | |
| GeneOntologyBiologicalProcess | ciliary body morphogenesis | 3.73e-04 | 6 | 104 | 2 | GO:0061073 | |
| GeneOntologyBiologicalProcess | pulmonary artery morphogenesis | 3.73e-04 | 6 | 104 | 2 | GO:0061156 | |
| GeneOntologyBiologicalProcess | axon development | RELN FN1 TNC LAMA2 LAMA3 TTC3 TENM2 SEMA5B LRP2 NOTCH2 NOTCH3 | 3.95e-04 | 642 | 104 | 11 | GO:0061564 |
| GeneOntologyBiologicalProcess | glomerulus vasculature development | 4.58e-04 | 30 | 104 | 3 | GO:0072012 | |
| GeneOntologyBiologicalProcess | branching morphogenesis of an epithelial tube | 5.05e-04 | 198 | 104 | 6 | GO:0048754 | |
| GeneOntologyBiologicalProcess | kidney vasculature development | 5.05e-04 | 31 | 104 | 3 | GO:0061440 | |
| GeneOntologyBiologicalProcess | renal system vasculature development | 5.05e-04 | 31 | 104 | 3 | GO:0061437 | |
| GeneOntologyBiologicalProcess | renal system vasculature morphogenesis | 5.20e-04 | 7 | 104 | 2 | GO:0061438 | |
| GeneOntologyBiologicalProcess | kidney vasculature morphogenesis | 5.20e-04 | 7 | 104 | 2 | GO:0061439 | |
| GeneOntologyBiologicalProcess | S-adenosylmethionine cycle | 5.20e-04 | 7 | 104 | 2 | GO:0033353 | |
| GeneOntologyBiologicalProcess | positive regulation of pigment cell differentiation | 5.20e-04 | 7 | 104 | 2 | GO:0050942 | |
| GeneOntologyBiologicalProcess | regulation of melanocyte differentiation | 5.20e-04 | 7 | 104 | 2 | GO:0045634 | |
| GeneOntologyBiologicalProcess | morphogenesis of an epithelial sheet | 5.35e-04 | 74 | 104 | 4 | GO:0002011 | |
| GeneOntologyBiologicalProcess | artery development | 5.70e-04 | 133 | 104 | 5 | GO:0060840 | |
| GeneOntologyBiologicalProcess | axonogenesis | 5.79e-04 | 566 | 104 | 10 | GO:0007409 | |
| GeneOntologyBiologicalProcess | positive regulation of cell differentiation | RELN FN1 SPINT1 LAMA2 ITGB3 CCN4 NELL1 TENM4 ADAMTS9 JAG1 LRP2 ADAMTS20 LTBP3 BRD1 NOTCH2 | 5.90e-04 | 1141 | 104 | 15 | GO:0045597 |
| GeneOntologyBiologicalProcess | animal organ morphogenesis | SPRY2 TNC ASH1L LAMA2 LAMA3 ADAMTS5 TECTA TDRD7 CELSR1 TENM3 ADAMTS9 JAG1 LRP2 LTBP3 CSMD1 NOTCH2 | 6.01e-04 | 1269 | 104 | 16 | GO:0009887 |
| GeneOntologyBiologicalProcess | glomerulus development | 6.22e-04 | 77 | 104 | 4 | GO:0032835 | |
| GeneOntologyBiologicalProcess | heart valve development | 6.53e-04 | 78 | 104 | 4 | GO:0003170 | |
| GeneOntologyBiologicalProcess | neuron projection morphogenesis | RELN FN1 LAMA2 LAMA3 TTC3 ADAM10 TENM2 CELSR2 SEMA5B LRP2 NOTCH2 NOTCH3 | 7.16e-04 | 802 | 104 | 12 | GO:0048812 |
| GeneOntologyBiologicalProcess | aorta development | 7.19e-04 | 80 | 104 | 4 | GO:0035904 | |
| GeneOntologyBiologicalProcess | regulation of cell adhesion | FLOT2 FN1 TNC LAMA2 LAMA3 ADAM10 ITGB2 ITGB3 FBLN2 CELSR2 TENM3 JAG1 MEGF10 | 7.79e-04 | 927 | 104 | 13 | GO:0030155 |
| GeneOntologyBiologicalProcess | receptor clustering | 8.26e-04 | 83 | 104 | 4 | GO:0043113 | |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection morphogenesis | RELN FN1 LAMA2 LAMA3 TTC3 ADAM10 TENM2 CELSR2 SEMA5B LRP2 NOTCH2 NOTCH3 | 8.60e-04 | 819 | 104 | 12 | GO:0120039 |
| GeneOntologyBiologicalProcess | wound healing | 8.73e-04 | 493 | 104 | 9 | GO:0042060 | |
| GeneOntologyBiologicalProcess | positive regulation of developmental pigmentation | 8.86e-04 | 9 | 104 | 2 | GO:0048087 | |
| GeneOntologyBiologicalProcess | regulation of pigment cell differentiation | 8.86e-04 | 9 | 104 | 2 | GO:0050932 | |
| GeneOntologyBiologicalProcess | cell-cell adhesion via plasma-membrane adhesion molecules | 1.05e-03 | 313 | 104 | 7 | GO:0098742 | |
| GeneOntologyBiologicalProcess | regulation of cell migration | SPRY2 RELN FN1 TNC LAMA2 LAMA3 ADAM10 ITGB3 F10 CCN4 EGF SEMA5B ADAMTS9 JAG1 RECK | 1.08e-03 | 1211 | 104 | 15 | GO:0030334 |
| GeneOntologyBiologicalProcess | glomerular epithelial cell development | 1.10e-03 | 10 | 104 | 2 | GO:0072310 | |
| GeneOntologyBiologicalProcess | podocyte development | 1.10e-03 | 10 | 104 | 2 | GO:0072015 | |
| GeneOntologyBiologicalProcess | regulation of cellular response to growth factor stimulus | 1.15e-03 | 412 | 104 | 8 | GO:0090287 | |
| GeneOntologyBiologicalProcess | epithelial tube branching involved in lung morphogenesis | 1.15e-03 | 41 | 104 | 3 | GO:0060441 | |
| GeneOntologyBiologicalProcess | artery morphogenesis | 1.21e-03 | 92 | 104 | 4 | GO:0048844 | |
| GeneOntologyBiologicalProcess | glomerulus morphogenesis | 1.34e-03 | 11 | 104 | 2 | GO:0072102 | |
| GeneOntologyBiologicalProcess | regulation of vasculature development | 1.51e-03 | 430 | 104 | 8 | GO:1901342 | |
| GeneOntologyBiologicalProcess | regulation of embryonic development | 1.59e-03 | 99 | 104 | 4 | GO:0045995 | |
| GeneOntologyBiologicalProcess | epithelial fluid transport | 1.61e-03 | 12 | 104 | 2 | GO:0042045 | |
| GeneOntologyBiologicalProcess | symbiont entry into host cell | 1.67e-03 | 169 | 104 | 5 | GO:0046718 | |
| GeneOntologyBiologicalProcess | receptor localization to synapse | 1.71e-03 | 101 | 104 | 4 | GO:0097120 | |
| GeneOntologyBiologicalProcess | camera-type eye morphogenesis | 1.75e-03 | 171 | 104 | 5 | GO:0048593 | |
| GeneOntologyBiologicalProcess | inner ear development | 1.79e-03 | 253 | 104 | 6 | GO:0048839 | |
| GeneOntologyBiologicalProcess | response to wounding | 1.82e-03 | 659 | 104 | 10 | GO:0009611 | |
| GeneOntologyBiologicalProcess | regulation of cell motility | SPRY2 RELN FN1 TNC LAMA2 LAMA3 ADAM10 ITGB3 F10 CCN4 EGF SEMA5B ADAMTS9 JAG1 RECK | 1.87e-03 | 1280 | 104 | 15 | GO:2000145 |
| GeneOntologyCellularComponent | extracellular matrix | COL4A1 LAMB4 RELN ZAN FN1 ADAMTS3 TNC LAMA2 LAMA3 PAPLN ADAMTS5 TECTA ADAM10 SSPOP SVEP1 CCN4 FBLN2 IGFBP7 ADAMTS9 ADAMTS20 LTBP1 LTBP2 LTBP3 MUC5AC FBN3 | 3.12e-15 | 656 | 108 | 25 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | COL4A1 LAMB4 RELN ZAN FN1 ADAMTS3 TNC LAMA2 LAMA3 PAPLN ADAMTS5 TECTA ADAM10 SSPOP SVEP1 CCN4 FBLN2 IGFBP7 ADAMTS9 ADAMTS20 LTBP1 LTBP2 LTBP3 MUC5AC FBN3 | 3.35e-15 | 658 | 108 | 25 | GO:0030312 |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | COL4A1 LAMB4 RELN FN1 ADAMTS3 TNC LAMA2 LAMA3 PAPLN ADAMTS5 ADAM10 SSPOP FBLN2 IGFBP7 ADAMTS9 ADAMTS20 LTBP1 LTBP2 LTBP3 | 2.82e-11 | 530 | 108 | 19 | GO:0062023 |
| GeneOntologyCellularComponent | basement membrane | 3.32e-06 | 122 | 108 | 7 | GO:0005604 | |
| GeneOntologyCellularComponent | protein complex involved in cell adhesion | 1.34e-05 | 59 | 108 | 5 | GO:0098636 | |
| GeneOntologyCellularComponent | endoplasmic reticulum lumen | 5.68e-05 | 332 | 108 | 9 | GO:0005788 | |
| GeneOntologyCellularComponent | integrin complex | 5.96e-04 | 32 | 108 | 3 | GO:0008305 | |
| Domain | EGF_1 | CNTNAP3B CLEC18A LAMB4 RELN STAB2 ZAN FN1 CLEC18B TNC CNTNAP3 LAMA2 LAMA3 CLEC18C SSPOP ITGB2 ITGB3 TENM2 VWDE ITGB5 F10 SVEP1 STAB1 NELL1 CELSR1 FBLN2 TENM4 EGF CELSR2 TENM3 JAG1 CNTNAP4 LRP2 DLK2 LTBP1 LTBP2 LTBP3 C6 FBN3 MEGF10 NOTCH2 NOTCH3 | 3.90e-49 | 255 | 107 | 41 | PS00022 |
| Domain | EGF_2 | CNTNAP3B CLEC18A LAMB4 RELN STAB2 ZAN CLEC18B TNC CNTNAP3 LAMA2 LAMA3 CLEC18C SSPOP ITGB2 ITGB3 TENM2 VWDE ITGB5 F10 SVEP1 STAB1 NELL1 CELSR1 FBLN2 TENM4 EGF CELSR2 TENM3 JAG1 CNTNAP4 LRP2 DLK2 LTBP1 LTBP2 LTBP3 C6 FBN3 MEGF10 NOTCH2 NOTCH3 | 1.04e-46 | 265 | 107 | 40 | PS01186 |
| Domain | EGF-like_CS | CLEC18A LAMB4 RELN STAB2 ZAN FN1 CLEC18B TNC CNTNAP3 LAMA2 LAMA3 CLEC18C ITGB2 ITGB3 TENM2 VWDE ITGB5 F10 SVEP1 STAB1 NELL1 CELSR1 FBLN2 TENM4 EGF CELSR2 TENM3 JAG1 CNTNAP4 LRP2 DLK2 LTBP1 LTBP2 LTBP3 C6 FBN3 MEGF10 NOTCH2 NOTCH3 | 2.67e-45 | 261 | 107 | 39 | IPR013032 |
| Domain | EGF | CNTNAP3B CLEC18A RELN STAB2 ZAN CLEC18B TNC CNTNAP3 LAMA2 LAMA3 CLEC18C TECTA TENM2 VWDE ITGB5 F10 SVEP1 STAB1 NELL1 CELSR1 FBLN2 TENM4 EGF CELSR2 TENM3 JAG1 CNTNAP4 LRP2 DLK2 ADGRE5 LTBP1 LTBP2 LTBP3 FBN3 MEGF10 NOTCH2 NOTCH3 | 9.15e-44 | 235 | 107 | 37 | SM00181 |
| Domain | EGF-like_dom | CNTNAP3B CLEC18A RELN STAB2 ZAN CLEC18B TNC CNTNAP3 LAMA2 LAMA3 CLEC18C TECTA TENM2 VWDE F10 SVEP1 STAB1 NELL1 CELSR1 FBLN2 TENM4 EGF CELSR2 TENM3 JAG1 CNTNAP4 LRP2 DLK2 ADGRE5 LTBP1 LTBP2 LTBP3 C6 FBN3 MEGF10 NOTCH2 NOTCH3 | 8.83e-43 | 249 | 107 | 37 | IPR000742 |
| Domain | EGF_3 | CNTNAP3B CLEC18A RELN STAB2 ZAN CLEC18B TNC CNTNAP3 CLEC18C SSPOP TENM2 VWDE F10 SVEP1 STAB1 NELL1 CELSR1 FBLN2 TENM4 EGF CELSR2 TENM3 JAG1 CNTNAP4 LRP2 DLK2 ADGRE5 LTBP1 LTBP2 LTBP3 C6 FBN3 MEGF10 NOTCH2 NOTCH3 | 2.03e-40 | 235 | 107 | 35 | PS50026 |
| Domain | EGF | STAB2 ZAN TNC CNTNAP3 TECTA ITGB3 ITGB5 F10 SVEP1 STAB1 CELSR1 EGF CELSR2 JAG1 CNTNAP4 LRP2 DLK2 LTBP1 LTBP2 FBN3 NOTCH2 NOTCH3 | 6.16e-27 | 126 | 107 | 22 | PF00008 |
| Domain | EGF_extracell | RELN STAB2 TNC ITGB2 ITGB3 ITGB5 SVEP1 STAB1 NELL1 TENM4 TENM3 JAG1 LRP2 DLK2 LTBP2 MEGF10 NOTCH3 | 6.46e-25 | 60 | 107 | 17 | IPR013111 |
| Domain | EGF_2 | RELN STAB2 TNC ITGB2 ITGB3 ITGB5 SVEP1 STAB1 NELL1 TENM4 TENM3 JAG1 LRP2 DLK2 LTBP2 MEGF10 NOTCH3 | 6.46e-25 | 60 | 107 | 17 | PF07974 |
| Domain | EGF_CA | STAB2 TENM2 F10 SVEP1 STAB1 NELL1 CELSR1 FBLN2 EGF CELSR2 JAG1 LRP2 DLK2 ADGRE5 LTBP1 LTBP2 LTBP3 FBN3 NOTCH2 NOTCH3 | 5.90e-24 | 122 | 107 | 20 | SM00179 |
| Domain | EGF-like_Ca-bd_dom | STAB2 TENM2 F10 SVEP1 STAB1 NELL1 CELSR1 FBLN2 EGF CELSR2 JAG1 LRP2 DLK2 ADGRE5 LTBP1 LTBP2 LTBP3 FBN3 NOTCH2 NOTCH3 | 8.33e-24 | 124 | 107 | 20 | IPR001881 |
| Domain | Growth_fac_rcpt_ | STAB2 TNC LAMA3 SVEP1 STAB1 CCN4 NELL1 CELSR1 FBLN2 EGF CELSR2 IGFBP7 JAG1 LRP2 ADGRE5 LTBP1 LTBP2 LTBP3 FBN3 NOTCH2 NOTCH3 | 3.07e-23 | 156 | 107 | 21 | IPR009030 |
| Domain | ASX_HYDROXYL | F10 SVEP1 NELL1 CELSR1 FBLN2 EGF CELSR2 JAG1 LRP2 DLK2 ADGRE5 LTBP1 LTBP2 LTBP3 FBN3 NOTCH2 NOTCH3 | 9.24e-21 | 100 | 107 | 17 | PS00010 |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | F10 SVEP1 NELL1 CELSR1 FBLN2 EGF CELSR2 JAG1 LRP2 DLK2 ADGRE5 LTBP1 LTBP2 LTBP3 FBN3 NOTCH2 NOTCH3 | 2.64e-20 | 106 | 107 | 17 | IPR000152 |
| Domain | EGF_Ca-bd_CS | F10 SVEP1 NELL1 FBLN2 EGF JAG1 LRP2 DLK2 ADGRE5 LTBP1 LTBP2 LTBP3 FBN3 NOTCH2 NOTCH3 | 8.94e-18 | 97 | 107 | 15 | IPR018097 |
| Domain | EGF_CA | F10 SVEP1 NELL1 FBLN2 EGF JAG1 LRP2 DLK2 ADGRE5 LTBP1 LTBP2 LTBP3 FBN3 NOTCH2 NOTCH3 | 1.23e-17 | 99 | 107 | 15 | PS01187 |
| Domain | EGF_CA | SVEP1 NELL1 FBLN2 EGF JAG1 LRP2 ADGRE5 LTBP1 LTBP2 LTBP3 FBN3 NOTCH2 NOTCH3 | 2.08e-15 | 86 | 107 | 13 | PF07645 |
| Domain | hEGF | 2.98e-14 | 28 | 107 | 9 | PF12661 | |
| Domain | TSP_1 | ADAMTS3 PAPLN ADAMTS5 THSD7B SSPOP CCN4 SEMA5B ADAMTS9 ADAMTS20 C6 | 2.46e-12 | 63 | 107 | 10 | PF00090 |
| Domain | TSP1 | ADAMTS3 PAPLN ADAMTS5 THSD7B SSPOP CCN4 SEMA5B ADAMTS9 ADAMTS20 C6 | 3.41e-12 | 65 | 107 | 10 | SM00209 |
| Domain | TSP1_rpt | ADAMTS3 PAPLN ADAMTS5 THSD7B SSPOP CCN4 SEMA5B ADAMTS9 ADAMTS20 C6 | 3.41e-12 | 65 | 107 | 10 | IPR000884 |
| Domain | TSP1 | ADAMTS3 PAPLN ADAMTS5 THSD7B SSPOP CCN4 SEMA5B ADAMTS9 ADAMTS20 C6 | 3.41e-12 | 65 | 107 | 10 | PS50092 |
| Domain | EGF_Lam | 1.84e-11 | 35 | 107 | 8 | SM00180 | |
| Domain | VWC | 3.77e-11 | 38 | 107 | 8 | SM00214 | |
| Domain | Laminin_EGF | 3.77e-11 | 38 | 107 | 8 | IPR002049 | |
| Domain | Laminin_G_2 | 5.88e-11 | 40 | 107 | 8 | PF02210 | |
| Domain | VWF_dom | 8.94e-11 | 42 | 107 | 8 | IPR001007 | |
| Domain | LamG | 1.33e-10 | 44 | 107 | 8 | SM00282 | |
| Domain | EGF_LAM_2 | 3.03e-10 | 30 | 107 | 7 | PS50027 | |
| Domain | EGF_LAM_1 | 3.03e-10 | 30 | 107 | 7 | PS01248 | |
| Domain | VWC_out | 7.84e-10 | 19 | 107 | 6 | SM00215 | |
| Domain | Laminin_EGF | 9.79e-10 | 35 | 107 | 7 | PF00053 | |
| Domain | Laminin_G | 1.35e-09 | 58 | 107 | 8 | IPR001791 | |
| Domain | VWFC_2 | 1.81e-09 | 38 | 107 | 7 | PS50184 | |
| Domain | LAM_G_DOMAIN | 1.81e-09 | 38 | 107 | 7 | PS50025 | |
| Domain | TIL_dom | 1.08e-08 | 14 | 107 | 5 | IPR002919 | |
| Domain | VWD | 2.33e-08 | 16 | 107 | 5 | SM00216 | |
| Domain | VWF_type-D | 2.33e-08 | 16 | 107 | 5 | IPR001846 | |
| Domain | VWFD | 2.33e-08 | 16 | 107 | 5 | PS51233 | |
| Domain | VWD | 2.33e-08 | 16 | 107 | 5 | PF00094 | |
| Domain | TB | 3.52e-08 | 7 | 107 | 4 | PF00683 | |
| Domain | VWFC_1 | 5.20e-08 | 36 | 107 | 6 | PS01208 | |
| Domain | - | 7.00e-08 | 8 | 107 | 4 | 3.90.290.10 | |
| Domain | - | 7.16e-08 | 95 | 107 | 8 | 2.60.120.200 | |
| Domain | TB | 1.25e-07 | 9 | 107 | 4 | PS51364 | |
| Domain | TB_dom | 1.25e-07 | 9 | 107 | 4 | IPR017878 | |
| Domain | ADAM_spacer1 | 1.74e-07 | 23 | 107 | 5 | IPR010294 | |
| Domain | ADAM_spacer1 | 1.74e-07 | 23 | 107 | 5 | PF05986 | |
| Domain | Rhs_assc_core | 1.83e-07 | 3 | 107 | 3 | IPR022385 | |
| Domain | Peptidase_M12B_ADAM-TS | 2.19e-07 | 24 | 107 | 5 | IPR013273 | |
| Domain | - | 3.26e-07 | 11 | 107 | 4 | 2.40.155.10 | |
| Domain | GFP-like | 3.26e-07 | 11 | 107 | 4 | IPR023413 | |
| Domain | cEGF | 3.36e-07 | 26 | 107 | 5 | IPR026823 | |
| Domain | cEGF | 3.36e-07 | 26 | 107 | 5 | PF12662 | |
| Domain | TIL | 4.86e-07 | 12 | 107 | 4 | PF01826 | |
| Domain | C8 | 4.86e-07 | 12 | 107 | 4 | PF08742 | |
| Domain | ConA-like_dom | CNTNAP3B ZAN CNTNAP3 LAMA2 LAMA3 SVEP1 NELL1 CELSR1 CELSR2 CNTNAP4 | 5.22e-07 | 219 | 107 | 10 | IPR013320 |
| Domain | Unchr_dom_Cys-rich | 7.00e-07 | 13 | 107 | 4 | IPR014853 | |
| Domain | C8 | 7.00e-07 | 13 | 107 | 4 | SM00832 | |
| Domain | Tox-GHH_dom | 7.28e-07 | 4 | 107 | 3 | IPR028916 | |
| Domain | Ten_N | 7.28e-07 | 4 | 107 | 3 | IPR009471 | |
| Domain | Ten_N | 7.28e-07 | 4 | 107 | 3 | PF06484 | |
| Domain | TENEURIN_N | 7.28e-07 | 4 | 107 | 3 | PS51361 | |
| Domain | Tox-GHH | 7.28e-07 | 4 | 107 | 3 | PF15636 | |
| Domain | YD | 1.81e-06 | 5 | 107 | 3 | IPR006530 | |
| Domain | Peptidase_M12B_N | 2.77e-06 | 39 | 107 | 5 | IPR002870 | |
| Domain | Pep_M12B_propep | 2.77e-06 | 39 | 107 | 5 | PF01562 | |
| Domain | - | 2.77e-06 | 39 | 107 | 5 | 2.120.10.30 | |
| Domain | DISINTEGRIN_1 | 3.15e-06 | 40 | 107 | 5 | PS00427 | |
| Domain | Reprolysin | 3.15e-06 | 40 | 107 | 5 | PF01421 | |
| Domain | ADAM_MEPRO | 3.15e-06 | 40 | 107 | 5 | PS50215 | |
| Domain | DISINTEGRIN_2 | 3.15e-06 | 40 | 107 | 5 | PS50214 | |
| Domain | Peptidase_M12B | 3.15e-06 | 40 | 107 | 5 | IPR001590 | |
| Domain | Disintegrin_dom | 3.57e-06 | 41 | 107 | 5 | IPR001762 | |
| Domain | Integrin_bsu_cyt_dom | 3.61e-06 | 6 | 107 | 3 | IPR014836 | |
| Domain | Integrin_b_cyt | 3.61e-06 | 6 | 107 | 3 | SM01241 | |
| Domain | Integrin_b_cyt | 3.61e-06 | 6 | 107 | 3 | PF08725 | |
| Domain | FA58C | 5.65e-06 | 21 | 107 | 4 | SM00231 | |
| Domain | FA58C_3 | 5.65e-06 | 21 | 107 | 4 | PS50022 | |
| Domain | FA58C_1 | 5.65e-06 | 21 | 107 | 4 | PS01285 | |
| Domain | FA58C_2 | 5.65e-06 | 21 | 107 | 4 | PS01286 | |
| Domain | Ldl_recept_a | 5.72e-06 | 45 | 107 | 5 | PF00057 | |
| Domain | Integrin_bsu_tail | 6.29e-06 | 7 | 107 | 3 | IPR012896 | |
| Domain | TLV_coat | 6.29e-06 | 7 | 107 | 3 | PF00429 | |
| Domain | Integrin_B_tail | 6.29e-06 | 7 | 107 | 3 | SM01242 | |
| Domain | Integrin_B_tail | 6.29e-06 | 7 | 107 | 3 | PF07965 | |
| Domain | 6-blade_b-propeller_TolB-like | 6.39e-06 | 46 | 107 | 5 | IPR011042 | |
| Domain | LDLRA_1 | 7.91e-06 | 48 | 107 | 5 | PS01209 | |
| Domain | LDLRA_2 | 8.76e-06 | 49 | 107 | 5 | PS50068 | |
| Domain | LDrepeatLR_classA_rpt | 8.76e-06 | 49 | 107 | 5 | IPR002172 | |
| Domain | LDLa | 8.76e-06 | 49 | 107 | 5 | SM00192 | |
| Domain | F5_F8_type_C | 9.90e-06 | 24 | 107 | 4 | PF00754 | |
| Domain | FA58C | 9.90e-06 | 24 | 107 | 4 | IPR000421 | |
| Domain | Integrin_beta | 1.00e-05 | 8 | 107 | 3 | PF00362 | |
| Domain | TLV/ENV_coat_polyprotein | 1.00e-05 | 8 | 107 | 3 | IPR018154 | |
| Domain | INB | 1.00e-05 | 8 | 107 | 3 | SM00187 | |
| Domain | Integrin_bsu_VWA | 1.00e-05 | 8 | 107 | 3 | IPR002369 | |
| Domain | Integrin_bsu | 1.50e-05 | 9 | 107 | 3 | IPR015812 | |
| Domain | Integin_beta_N | 1.50e-05 | 9 | 107 | 3 | IPR033760 | |
| Domain | INTEGRIN_BETA | 1.50e-05 | 9 | 107 | 3 | PS00243 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | COL4A1 FN1 ADAMTS3 TNC LAMA2 LAMA3 ADAMTS5 ADAM10 ITGB2 ITGB3 ITGB5 FBLN2 ADAMTS9 LTBP1 LTBP2 LTBP3 FBN3 | 7.27e-13 | 300 | 80 | 17 | M610 |
| Pathway | REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS | ADAMTS3 ADAMTS5 THSD7B SSPOP SEMA5B ADAMTS9 ADAMTS20 MUC5AC NOTCH2 NOTCH3 | 4.32e-12 | 68 | 80 | 10 | M27303 |
| Pathway | REACTOME_MOLECULES_ASSOCIATED_WITH_ELASTIC_FIBRES | 2.54e-11 | 37 | 80 | 8 | M27134 | |
| Pathway | REACTOME_ELASTIC_FIBRE_FORMATION | 1.13e-10 | 44 | 80 | 8 | M26969 | |
| Pathway | KEGG_ECM_RECEPTOR_INTERACTION | 1.00e-09 | 84 | 80 | 9 | M7098 | |
| Pathway | REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS | 1.93e-09 | 39 | 80 | 7 | M27417 | |
| Pathway | REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS | 1.93e-09 | 39 | 80 | 7 | MM15165 | |
| Pathway | REACTOME_DISEASES_OF_GLYCOSYLATION | ADAMTS3 ADAMTS5 THSD7B SSPOP SEMA5B ADAMTS9 ADAMTS20 MUC5AC NOTCH2 NOTCH3 | 7.56e-09 | 143 | 80 | 10 | M27275 |
| Pathway | KEGG_FOCAL_ADHESION | 1.51e-08 | 199 | 80 | 11 | M7253 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | COL4A1 FN1 ADAMTS3 TNC ADAMTS5 ADAM10 ITGB2 ITGB3 FBLN2 LTBP1 LTBP2 LTBP3 | 2.19e-08 | 258 | 80 | 12 | MM14572 |
| Pathway | REACTOME_MOLECULES_ASSOCIATED_WITH_ELASTIC_FIBRES | 2.22e-08 | 32 | 80 | 6 | MM14854 | |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | 3.90e-08 | 59 | 80 | 7 | M27218 | |
| Pathway | REACTOME_ELASTIC_FIBRE_FORMATION | 7.76e-08 | 39 | 80 | 6 | MM14601 | |
| Pathway | WP_FOCAL_ADHESION | 9.77e-08 | 187 | 80 | 10 | MM15913 | |
| Pathway | WP_FOCAL_ADHESION | 1.75e-07 | 199 | 80 | 10 | M39402 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | 1.80e-07 | 109 | 80 | 8 | MM15164 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | 2.07e-07 | 111 | 80 | 8 | M27416 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 2.32e-07 | 76 | 80 | 7 | M27219 | |
| Pathway | WP_CANONICAL_AND_NONCANONICAL_NOTCH_SIGNALING | 3.80e-07 | 27 | 80 | 5 | M39545 | |
| Pathway | REACTOME_DISEASES_OF_METABOLISM | ADAMTS3 ADAMTS5 THSD7B SSPOP SEMA5B ADAMTS9 ADAMTS20 MUC5AC NOTCH2 NOTCH3 | 1.42e-06 | 250 | 80 | 10 | M27554 |
| Pathway | REACTOME_SIGNALING_BY_NOTCH3 | 3.49e-06 | 19 | 80 | 4 | MM15594 | |
| Pathway | REACTOME_TGF_BETA_RECEPTOR_SIGNALING_ACTIVATES_SMADS | 6.60e-06 | 47 | 80 | 5 | M646 | |
| Pathway | WP_FOCAL_ADHESION_PI3KAKTMTORSIGNALING | 7.68e-06 | 302 | 80 | 10 | M39719 | |
| Pathway | KEGG_SMALL_CELL_LUNG_CANCER | 7.89e-06 | 84 | 80 | 6 | M3228 | |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | 8.46e-06 | 85 | 80 | 6 | M16441 | |
| Pathway | REACTOME_NOTCH3_ACTIVATION_AND_TRANSMISSION_OF_SIGNAL_TO_THE_NUCLEUS | 1.11e-05 | 25 | 80 | 4 | M27879 | |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | 1.42e-05 | 140 | 80 | 7 | M587 | |
| Pathway | WP_FOCAL_ADHESION_PI3KAKTMTOR_SIGNALING_PATHWAY | 1.49e-05 | 326 | 80 | 10 | MM15917 | |
| Pathway | REACTOME_SYNDECAN_INTERACTIONS | 1.53e-05 | 27 | 80 | 4 | M27217 | |
| Pathway | PID_NOTCH_PATHWAY | 2.04e-05 | 59 | 80 | 5 | M17 | |
| Pathway | WP_PI3KAKT_SIGNALING | 2.09e-05 | 339 | 80 | 10 | M39736 | |
| Pathway | PID_INTEGRIN1_PATHWAY | 3.54e-05 | 66 | 80 | 5 | M18 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E6_TO_NOTCH_SIGNALING_PATHWAY_N00380 | 3.73e-05 | 12 | 80 | 3 | M47532 | |
| Pathway | KEGG_MEDICUS_REFERENCE_NOTCH_SIGNALING_PATHWAY | 4.83e-05 | 13 | 80 | 3 | M47423 | |
| Pathway | REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION | FN1 ADAMTS3 TNC ADAMTS5 THSD7B TECTA ADAM10 SSPOP F10 IFIH1 DPH5 IGFBP7 SEMA5B ADAMTS9 SQSTM1 ADAMTS20 CHRDL1 LTBP1 FUT8 MUC5AC RECK | 5.23e-05 | 1475 | 80 | 21 | M19806 |
| Pathway | REACTOME_REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS | 6.03e-05 | 120 | 80 | 6 | MM14982 | |
| Pathway | REACTOME_TGF_BETA_RECEPTOR_SIGNALING_ACTIVATES_SMADS | 6.13e-05 | 38 | 80 | 4 | MM14874 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH | 6.80e-05 | 39 | 80 | 4 | MM14604 | |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | 6.99e-05 | 76 | 80 | 5 | MM14867 | |
| Pathway | REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION | FN1 ADAMTS3 TNC ADAMTS5 THSD7B TECTA ADAM10 SSPOP F10 IFIH1 DPH5 IGFBP7 SEMA5B ADAMTS9 ADAMTS20 CHRDL1 LTBP1 FUT8 MUC5AC RECK | 7.08e-05 | 1389 | 80 | 20 | MM15307 |
| Pathway | REACTOME_REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS | 7.24e-05 | 124 | 80 | 6 | M27285 | |
| Pathway | PID_UPA_UPAR_PATHWAY | 9.14e-05 | 42 | 80 | 4 | M174 | |
| Pathway | PID_INTEGRIN3_PATHWAY | 1.00e-04 | 43 | 80 | 4 | M53 | |
| Pathway | WP_DELTANOTCH_SIGNALING_PATHWAY | 1.01e-04 | 82 | 80 | 5 | MM15922 | |
| Pathway | WP_OVERVIEW_OF_NANOPARTICLE_EFFECTS | 1.60e-04 | 19 | 80 | 3 | M39473 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH3 | 1.68e-04 | 49 | 80 | 4 | M618 | |
| Pathway | REACTOME_SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX | 1.92e-04 | 94 | 80 | 5 | M1041 | |
| Pathway | WP_COMPLEMENT_SYSTEM | 2.12e-04 | 96 | 80 | 5 | M39581 | |
| Pathway | WP_SMALL_CELL_LUNG_CANCER | 2.12e-04 | 96 | 80 | 5 | M39834 | |
| Pathway | REACTOME_NOTCH2_ACTIVATION_AND_TRANSMISSION_OF_SIGNAL_TO_THE_NUCLEUS | 2.51e-04 | 22 | 80 | 3 | M27210 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ITGA_B_RHOGAP_RHOA_SIGNALING_PATHWAY | 2.87e-04 | 23 | 80 | 3 | M47537 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ITGA_B_RHOGEF_RHOA_SIGNALING_PATHWAY | 2.87e-04 | 23 | 80 | 3 | M47720 | |
| Pathway | REACTOME_SIGNALING_BY_TGFB_FAMILY_MEMBERS | 3.03e-04 | 161 | 80 | 6 | M27871 | |
| Pathway | REACTOME_DEFECTIVE_LFNG_CAUSES_SCDO3 | 3.15e-04 | 5 | 80 | 2 | M27411 | |
| Pathway | WP_COMPLEMENT_SYSTEM_IN_NEURONAL_DEVELOPMENT_AND_PLASTICITY | 3.36e-04 | 106 | 80 | 5 | M42535 | |
| Pathway | WP_HYPOTHESIZED_PATHWAYS_IN_PATHOGENESIS_OF_CARDIOVASCULAR_DISEASE | 3.70e-04 | 25 | 80 | 3 | M39713 | |
| Pathway | PID_INTEGRIN_CS_PATHWAY | 4.16e-04 | 26 | 80 | 3 | M47 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ITGA_B_FAK_CDC42_SIGNALING_PATHWAY | 4.16e-04 | 26 | 80 | 3 | M47719 | |
| Pathway | REACTOME_PRE_NOTCH_PROCESSING_IN_THE_ENDOPLASMIC_RETICULUM | 4.70e-04 | 6 | 80 | 2 | M27068 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ITGA_B_RHOG_RAC_SIGNALING_PATHWAY | 5.20e-04 | 28 | 80 | 3 | M47655 | |
| Pathway | REACTOME_SIGNALING_BY_TGFB_FAMILY_MEMBERS | 5.50e-04 | 118 | 80 | 5 | MM15588 | |
| Pathway | WP_CANCER_PATHWAYS | 5.69e-04 | 507 | 80 | 10 | M48302 | |
| Pathway | REACTOME_MET_ACTIVATES_PTK2_SIGNALING | 6.40e-04 | 30 | 80 | 3 | M27772 | |
| Pathway | REACTOME_LAMININ_INTERACTIONS | 6.40e-04 | 30 | 80 | 3 | M27216 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ITGA_B_TALIN_VINCULIN_SIGNALING_PATHWAY | 6.40e-04 | 30 | 80 | 3 | M47724 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ITGA_B_FAK_RAC_SIGNALING_PATHWAY | 6.40e-04 | 30 | 80 | 3 | M47718 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH1_T_7_9_NOTCH1_M1580_K2555_TRANSLOCATION_MUTANT | 6.56e-04 | 7 | 80 | 2 | M27199 | |
| Pathway | BIOCARTA_AGR_PATHWAY | 7.05e-04 | 31 | 80 | 3 | MM1343 | |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | 7.75e-04 | 32 | 80 | 3 | MM14924 | |
| Pathway | PID_SYNDECAN_4_PATHWAY | 7.75e-04 | 32 | 80 | 3 | M165 | |
| Pathway | REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES | 8.26e-04 | 532 | 80 | 10 | M27870 | |
| Pathway | BIOCARTA_AGR_PATHWAY | 8.49e-04 | 33 | 80 | 3 | M6220 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH2 | 8.49e-04 | 33 | 80 | 3 | M604 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PLASMIN_MEDIATED_ACTIVATION_OF_LATENT_TGF_BETA | 8.71e-04 | 8 | 80 | 2 | M47850 | |
| Pathway | REACTOME_SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX | 9.50e-04 | 77 | 80 | 4 | MM14670 | |
| Pathway | REACTOME_SIGNALING_BY_MET | 1.05e-03 | 79 | 80 | 4 | M27643 | |
| Pathway | KEGG_MEDICUS_REFERENCE_METHIONINE_DEGRADATION | 1.39e-03 | 10 | 80 | 2 | M47939 | |
| Pathway | REACTOME_MET_PROMOTES_CELL_MOTILITY | 1.61e-03 | 41 | 80 | 3 | M27778 | |
| Pathway | KEGG_MEDICUS_REFERENCE_NOTCH_PROTEOLYTIC_ACTIVATION | 1.69e-03 | 11 | 80 | 2 | M47865 | |
| Pathway | REACTOME_NOTCH4_ACTIVATION_AND_TRANSMISSION_OF_SIGNAL_TO_THE_NUCLEUS | 1.69e-03 | 11 | 80 | 2 | M27882 | |
| Pathway | PID_INTEGRIN4_PATHWAY | 1.69e-03 | 11 | 80 | 2 | M158 | |
| Pathway | WP_MIRNA_TARGETS_IN_ECM_AND_MEMBRANE_RECEPTORS | 1.84e-03 | 43 | 80 | 3 | M39565 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E6_TO_NOTCH_SIGNALING_PATHWAY_N00381 | 2.02e-03 | 12 | 80 | 2 | M47533 | |
| Pathway | WP_NOTCH_SIGNALING_WP268 | 2.10e-03 | 45 | 80 | 3 | M39571 | |
| Pathway | WP_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_IN_COLORECTAL_CANCER | 2.20e-03 | 161 | 80 | 5 | M39770 | |
| Pathway | PID_A6B1_A6B4_INTEGRIN_PATHWAY | 2.24e-03 | 46 | 80 | 3 | M239 | |
| Pathway | WP_NOTCH_SIGNALING_PATHWAY | 2.24e-03 | 46 | 80 | 3 | MM15971 | |
| Pathway | WP_MAMMARY_GLAND_DEVELOPMENT_PUBERTY_STAGE_2_OF_4 | 2.38e-03 | 13 | 80 | 2 | M39582 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E6_TO_NOTCH_SIGNALING_PATHWAY_N00382 | 2.38e-03 | 13 | 80 | 2 | M47534 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 2.38e-03 | 47 | 80 | 3 | MM14925 | |
| Pathway | KEGG_NOTCH_SIGNALING_PATHWAY | 2.38e-03 | 47 | 80 | 3 | M7946 | |
| Pathway | WP_MECHANOREGULATION_AND_PATHOLOGY_OF_YAPTAZ_VIA_HIPPO_AND_NONHIPPO_MECHANISMS | 2.38e-03 | 47 | 80 | 3 | M39829 | |
| Pathway | KEGG_PATHWAYS_IN_CANCER | 2.44e-03 | 325 | 80 | 7 | M12868 | |
| Pathway | REACTOME_SYNDECAN_INTERACTIONS | 2.77e-03 | 14 | 80 | 2 | MM14923 | |
| Pathway | WP_VEGFAVEGFR2_SIGNALING | 3.03e-03 | 431 | 80 | 8 | M39729 | |
| Pathway | REACTOME_ANCHORING_FIBRIL_FORMATION | 3.18e-03 | 15 | 80 | 2 | M27161 | |
| Pathway | REACTOME_P130CAS_LINKAGE_TO_MAPK_SIGNALING_FOR_INTEGRINS | 3.18e-03 | 15 | 80 | 2 | M12101 | |
| Pathway | REACTOME_GRB2_SOS_PROVIDES_LINKAGE_TO_MAPK_SIGNALING_FOR_INTEGRINS | 3.18e-03 | 15 | 80 | 2 | M1262 | |
| Pathway | REACTOME_GRB2_SOS_PROVIDES_LINKAGE_TO_MAPK_SIGNALING_FOR_INTEGRINS | 3.18e-03 | 15 | 80 | 2 | MM14959 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH1_HD_DOMAIN_MUTANTS_IN_CANCER | 3.18e-03 | 15 | 80 | 2 | M27202 | |
| Pubmed | ADAMTS3 PAPLN ADAMTS5 THSD7B SSPOP CCN4 SEMA5B ADAMTS9 ADAMTS20 C6 | 3.81e-14 | 75 | 108 | 10 | 20637190 | |
| Pubmed | COL4A1 RELN FN1 TNC LAMA2 LAMA3 ADAM10 SSPOP FBLN2 IGFBP7 LTBP1 LTBP2 | 3.30e-13 | 175 | 108 | 12 | 28071719 | |
| Pubmed | 4.56e-13 | 64 | 108 | 9 | 22261194 | ||
| Pubmed | COL4A1 FN1 TNC LAMA2 LAMA3 PAPLN ADAM10 FBLN2 IGFBP7 LTBP1 LTBP2 | 5.18e-12 | 167 | 108 | 11 | 22159717 | |
| Pubmed | Extracellular matrix secretion by cardiac fibroblasts: role of microRNA-29b and microRNA-30c. | COL4A1 FN1 TNC LAMA2 ADAMTS5 ADAM10 SVEP1 CCN4 FBLN2 IGFBP7 LTBP1 LTBP2 | 2.02e-11 | 248 | 108 | 12 | 24006456 |
| Pubmed | 3.39e-11 | 146 | 108 | 10 | 27068509 | ||
| Pubmed | Adamts18 modulates the development of the aortic arch and common carotid artery. | 1.71e-10 | 26 | 108 | 6 | 34189436 | |
| Pubmed | 2.58e-09 | 71 | 108 | 7 | 33541421 | ||
| Pubmed | 1.11e-08 | 50 | 108 | 6 | 23658023 | ||
| Pubmed | 1.32e-08 | 199 | 108 | 9 | 23382691 | ||
| Pubmed | Glycoproteomics Reveals Decorin Peptides With Anti-Myostatin Activity in Human Atrial Fibrillation. | 2.33e-08 | 97 | 108 | 7 | 27559042 | |
| Pubmed | Human CLEC18 Gene Cluster Contains C-type Lectins with Differential Glycan-binding Specificity. | 2.91e-08 | 3 | 108 | 3 | 26170455 | |
| Pubmed | 2.91e-08 | 3 | 108 | 3 | 10848816 | ||
| Pubmed | 2.91e-08 | 3 | 108 | 3 | 24753090 | ||
| Pubmed | 2.91e-08 | 3 | 108 | 3 | 16336259 | ||
| Pubmed | Endosomal TLR3 co-receptor CLEC18A enhances host immune response to viral infection. | 2.91e-08 | 3 | 108 | 3 | 33603190 | |
| Pubmed | 2.91e-08 | 3 | 108 | 3 | 10743502 | ||
| Pubmed | Notch signaling in stomach epithelial stem cell homeostasis. | 2.94e-08 | 29 | 108 | 5 | 21402740 | |
| Pubmed | 4.95e-08 | 32 | 108 | 5 | 23154389 | ||
| Pubmed | JAGGED1/NOTCH3 activation promotes aortic hypermuscularization and stenosis in elastin deficiency. | 6.15e-08 | 13 | 108 | 4 | 34990407 | |
| Pubmed | Mouse ten-m/Odz is a new family of dimeric type II transmembrane proteins expressed in many tissues. | 1.16e-07 | 4 | 108 | 3 | 10225957 | |
| Pubmed | 1.16e-07 | 4 | 108 | 3 | 15611103 | ||
| Pubmed | 1.16e-07 | 4 | 108 | 3 | 10551863 | ||
| Pubmed | 1.16e-07 | 4 | 108 | 3 | 16709836 | ||
| Pubmed | 1.16e-07 | 4 | 108 | 3 | 9008713 | ||
| Pubmed | The latent transforming growth factor beta binding protein (LTBP) family. | 1.16e-07 | 4 | 108 | 3 | 11104663 | |
| Pubmed | Association analysis of Notch pathway signalling genes in diabetic nephropathy. | 1.16e-07 | 4 | 108 | 3 | 21103979 | |
| Pubmed | All four members of the Ten-m/Odz family of transmembrane proteins form dimers. | 1.16e-07 | 4 | 108 | 3 | 12000766 | |
| Pubmed | 1.16e-07 | 4 | 108 | 3 | 16157329 | ||
| Pubmed | 1.55e-07 | 16 | 108 | 4 | 30579834 | ||
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | COL4A1 TRAF7 CNTNAP3 ADAM10 ITGB5 CELSR1 CELSR2 IGFBP7 TENM3 SQSTM1 ADGRE5 LTBP1 LTBP2 LTBP3 FUT8 NOTCH2 NOTCH3 | 1.80e-07 | 1201 | 108 | 17 | 35696571 |
| Pubmed | Protein interactome reveals converging molecular pathways among autism disorders. | SPRY2 FN1 TNC STAB1 TDRD7 NELL1 FBLN2 LTBP1 LTBP3 MEGF10 NOTCH2 NOTCH3 | 1.85e-07 | 560 | 108 | 12 | 21653829 |
| Pubmed | 2.60e-07 | 18 | 108 | 4 | 11311202 | ||
| Pubmed | Functional diversity of notch family genes in fetal lung development. | 2.90e-07 | 5 | 108 | 3 | 15064243 | |
| Pubmed | 2.90e-07 | 5 | 108 | 3 | 15882997 | ||
| Pubmed | Comprehensive proteomic characterization of stem cell-derived extracellular matrices. | 2.99e-07 | 86 | 108 | 6 | 28327460 | |
| Pubmed | 3.24e-07 | 210 | 108 | 8 | 16537572 | ||
| Pubmed | 4.05e-07 | 48 | 108 | 5 | 35247391 | ||
| Pubmed | 5.34e-07 | 153 | 108 | 7 | 25037231 | ||
| Pubmed | Characterization of Notch receptor expression in the developing mammalian heart and liver. | 5.78e-07 | 6 | 108 | 3 | 12244553 | |
| Pubmed | 5.78e-07 | 6 | 108 | 3 | 12358597 | ||
| Pubmed | 5.78e-07 | 6 | 108 | 3 | 22526456 | ||
| Pubmed | Aberrant expression of Notch signaling molecules in patients with immune thrombocytopenic purpura. | 5.78e-07 | 6 | 108 | 3 | 19603167 | |
| Pubmed | HIV-1-Tat protein promotes chemotaxis and invasive behavior by monocytes. | 5.78e-07 | 6 | 108 | 3 | 8757599 | |
| Pubmed | 5.78e-07 | 6 | 108 | 3 | 1694173 | ||
| Pubmed | 5.78e-07 | 6 | 108 | 3 | 9108364 | ||
| Pubmed | Promotion of tumor cell migration by extracellular matrix proteins in human pancreatic cancer. | 5.78e-07 | 6 | 108 | 3 | 19893454 | |
| Pubmed | 7.44e-07 | 23 | 108 | 4 | 26027930 | ||
| Pubmed | Structural basis for endosomal trafficking of diverse transmembrane cargos by PX-FERM proteins. | 7.77e-07 | 101 | 108 | 6 | 23382219 | |
| Pubmed | 8.91e-07 | 24 | 108 | 4 | 29791855 | ||
| Pubmed | 1.01e-06 | 7 | 108 | 3 | 10383933 | ||
| Pubmed | 1.01e-06 | 7 | 108 | 3 | 10079256 | ||
| Pubmed | The distribution of Notch receptors and their ligands during articular cartilage development. | 1.01e-06 | 7 | 108 | 3 | 12846471 | |
| Pubmed | Differentiation of CD11c+ CX3CR1+ cells in the small intestine requires Notch signaling. | 1.01e-06 | 7 | 108 | 3 | 24711412 | |
| Pubmed | 1.01e-06 | 7 | 108 | 3 | 10930463 | ||
| Pubmed | 1.01e-06 | 7 | 108 | 3 | 8798654 | ||
| Pubmed | 1.01e-06 | 7 | 108 | 3 | 10625539 | ||
| Pubmed | 1.01e-06 | 7 | 108 | 3 | 12915301 | ||
| Pubmed | Conditional deletion of beta1-integrin in astroglia causes partial reactive gliosis. | 1.06e-06 | 25 | 108 | 4 | 19373938 | |
| Pubmed | Notch signaling prevents mucous metaplasia in mouse conducting airways during postnatal development. | 1.46e-06 | 27 | 108 | 4 | 21791528 | |
| Pubmed | 1.61e-06 | 8 | 108 | 3 | 21041365 | ||
| Pubmed | P4 down-regulates Jagged2 and Notch1 expression during primordial folliculogenesis. | 1.61e-06 | 8 | 108 | 3 | 22652674 | |
| Pubmed | 1.61e-06 | 8 | 108 | 3 | 10331952 | ||
| Pubmed | Expression of Hairy/Enhancer of Split genes, Hes1 and Hes5, during murine nephron morphogenesis. | 1.61e-06 | 8 | 108 | 3 | 15465493 | |
| Pubmed | 1.61e-06 | 8 | 108 | 3 | 9858718 | ||
| Pubmed | 1.61e-06 | 8 | 108 | 3 | 11044610 | ||
| Pubmed | 1.61e-06 | 8 | 108 | 3 | 1383086 | ||
| Pubmed | 1.61e-06 | 8 | 108 | 3 | 22156581 | ||
| Pubmed | Notch1 and Jagged1 expression by the developing pulmonary vasculature. | 1.61e-06 | 8 | 108 | 3 | 12242716 | |
| Pubmed | 1.97e-06 | 29 | 108 | 4 | 22613833 | ||
| Pubmed | 2.26e-06 | 30 | 108 | 4 | 16524929 | ||
| Pubmed | 2.41e-06 | 9 | 108 | 3 | 11118901 | ||
| Pubmed | 2.41e-06 | 9 | 108 | 3 | 16245338 | ||
| Pubmed | 2.41e-06 | 9 | 108 | 3 | 9882526 | ||
| Pubmed | 2.59e-06 | 31 | 108 | 4 | 22274697 | ||
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | SPRY2 LAMB4 FN1 ZNF226 SSPOP DNAH14 CCN4 ADAMTS9 LRP2 C6 FBN3 MEGF10 | 3.22e-06 | 736 | 108 | 12 | 29676528 |
| Pubmed | Spatiotemporal expression of Notch receptors and ligands in developing mouse placenta. | 3.44e-06 | 10 | 108 | 3 | 23665443 | |
| Pubmed | 3.44e-06 | 10 | 108 | 3 | 24015274 | ||
| Pubmed | 3.44e-06 | 10 | 108 | 3 | 11167130 | ||
| Pubmed | 3.44e-06 | 10 | 108 | 3 | 38713721 | ||
| Pubmed | Links between alpha-catenin, NF-kappaB, and squamous cell carcinoma in skin. | 4.27e-06 | 35 | 108 | 4 | 16452166 | |
| Pubmed | Notch signaling regulates smooth muscle differentiation of epicardium-derived cells. | 4.27e-06 | 35 | 108 | 4 | 21252157 | |
| Pubmed | Binding of mouse and human fibulin-2 to extracellular matrix ligands. | 4.72e-06 | 11 | 108 | 3 | 7500359 | |
| Pubmed | 4.72e-06 | 11 | 108 | 3 | 33909046 | ||
| Pubmed | A family of mammalian Fringe genes implicated in boundary determination and the Notch pathway. | 4.72e-06 | 11 | 108 | 3 | 9187150 | |
| Pubmed | Coexpression of Cux-1 and Notch signaling pathway components during kidney development. | 4.72e-06 | 11 | 108 | 3 | 15499562 | |
| Pubmed | 4.72e-06 | 11 | 108 | 3 | 10878608 | ||
| Pubmed | 4.72e-06 | 11 | 108 | 3 | 12866128 | ||
| Pubmed | Galnt1 is required for normal heart valve development and cardiac function. | 4.80e-06 | 36 | 108 | 4 | 25615642 | |
| Pubmed | Transcriptome-based systematic identification of extracellular matrix proteins. | 4.94e-06 | 79 | 108 | 5 | 18757743 | |
| Pubmed | 5.37e-06 | 37 | 108 | 4 | 22432025 | ||
| Pubmed | 6.28e-06 | 12 | 108 | 3 | 19693543 | ||
| Pubmed | 6.28e-06 | 12 | 108 | 3 | 12606711 | ||
| Pubmed | 6.28e-06 | 12 | 108 | 3 | 15465494 | ||
| Pubmed | 6.28e-06 | 12 | 108 | 3 | 32147304 | ||
| Pubmed | 6.28e-06 | 12 | 108 | 3 | 14732396 | ||
| Pubmed | Insights on ADAMTS proteases and ADAMTS-like proteins from mammalian genetics. | 6.28e-06 | 12 | 108 | 3 | 25770910 | |
| Pubmed | Jagged1 is Essential for Radial Glial Maintenance in the Cortical Proliferative Zone. | 8.14e-06 | 13 | 108 | 3 | 31202705 | |
| Pubmed | Basal lamina molecules are concentrated in myogenic regions of the mouse limb bud. | 8.14e-06 | 13 | 108 | 3 | 9833687 | |
| Pubmed | Vascular expression of Notch pathway receptors and ligands is restricted to arterial vessels. | 8.14e-06 | 13 | 108 | 3 | 11578869 | |
| Interaction | LTBP1 interactions | 2.14e-08 | 92 | 102 | 8 | int:LTBP1 | |
| Interaction | NTN5 interactions | 1.18e-07 | 24 | 102 | 5 | int:NTN5 | |
| Interaction | FBXO2 interactions | CNTNAP3B FN1 SPINT1 CNTNAP3 LAMA3 ADAM10 ERVMER34-1 ITGB5 TENM3 JAG1 LRP2 NOTCH2 NOTCH3 | 1.58e-07 | 411 | 102 | 13 | int:FBXO2 |
| Interaction | PRG2 interactions | CNTNAP3B SPINT1 CNTNAP3 ADAM10 VWDE CELSR1 CELSR2 LTBP3 FUT8 NOTCH2 NOTCH3 | 2.13e-07 | 285 | 102 | 11 | int:PRG2 |
| Interaction | TRGV3 interactions | 3.44e-07 | 55 | 102 | 6 | int:TRGV3 | |
| Interaction | FBLN2 interactions | 1.03e-06 | 66 | 102 | 6 | int:FBLN2 | |
| Interaction | GREM2 interactions | 1.15e-06 | 37 | 102 | 5 | int:GREM2 | |
| Interaction | ZNF696 interactions | 1.23e-06 | 68 | 102 | 6 | int:ZNF696 | |
| Interaction | ZDHHC15 interactions | 3.38e-06 | 125 | 102 | 7 | int:ZDHHC15 | |
| Interaction | CFC1 interactions | 3.56e-06 | 126 | 102 | 7 | int:CFC1 | |
| Interaction | ZNF594 interactions | 4.34e-06 | 7 | 102 | 3 | int:ZNF594 | |
| Interaction | FBN1 interactions | 5.88e-06 | 51 | 102 | 5 | int:FBN1 | |
| Interaction | NELL2 interactions | 7.12e-06 | 53 | 102 | 5 | int:NELL2 | |
| Interaction | ZNF408 interactions | 9.01e-06 | 145 | 102 | 7 | int:ZNF408 | |
| Interaction | HOXA1 interactions | 1.32e-05 | 356 | 102 | 10 | int:HOXA1 | |
| Interaction | TMEM106A interactions | 1.32e-05 | 214 | 102 | 8 | int:TMEM106A | |
| Interaction | FBN2 interactions | 1.95e-05 | 65 | 102 | 5 | int:FBN2 | |
| Interaction | TNS2 interactions | 2.59e-05 | 235 | 102 | 8 | int:TNS2 | |
| Interaction | CEACAM8 interactions | 3.17e-05 | 119 | 102 | 6 | int:CEACAM8 | |
| Interaction | ZNF709 interactions | 3.47e-05 | 13 | 102 | 3 | int:ZNF709 | |
| Interaction | SDF2L1 interactions | CNTNAP3B SPINT1 CNTNAP3 PAPLN ADAM10 ERVMER34-1 VWDE F10 CELSR1 | 3.78e-05 | 322 | 102 | 9 | int:SDF2L1 |
| Interaction | CST11 interactions | 3.92e-05 | 75 | 102 | 5 | int:CST11 | |
| Interaction | IGFL3 interactions | 3.92e-05 | 75 | 102 | 5 | int:IGFL3 | |
| Interaction | RNASE4 interactions | 4.40e-05 | 14 | 102 | 3 | int:RNASE4 | |
| Interaction | LGALS1 interactions | 4.79e-05 | 332 | 102 | 9 | int:LGALS1 | |
| Interaction | ZNF526 interactions | 5.35e-05 | 80 | 102 | 5 | int:ZNF526 | |
| Interaction | PSG8 interactions | 5.42e-05 | 41 | 102 | 4 | int:PSG8 | |
| Interaction | ZNF260 interactions | 6.72e-05 | 16 | 102 | 3 | int:ZNF260 | |
| Interaction | ZNF628 interactions | 6.72e-05 | 16 | 102 | 3 | int:ZNF628 | |
| Interaction | ZNF497 interactions | 7.19e-05 | 44 | 102 | 4 | int:ZNF497 | |
| Interaction | ZNF316 interactions | 8.57e-05 | 46 | 102 | 4 | int:ZNF316 | |
| Interaction | ZNF865 interactions | 9.33e-05 | 47 | 102 | 4 | int:ZNF865 | |
| Interaction | C1QTNF1 interactions | 9.33e-05 | 47 | 102 | 4 | int:C1QTNF1 | |
| Interaction | ITGB5 interactions | 1.03e-04 | 147 | 102 | 6 | int:ITGB5 | |
| Interaction | ZNF263 interactions | 1.11e-04 | 149 | 102 | 6 | int:ZNF263 | |
| Interaction | ZNF358 interactions | 1.15e-04 | 19 | 102 | 3 | int:ZNF358 | |
| Interaction | ZNF627 interactions | 1.35e-04 | 20 | 102 | 3 | int:ZNF627 | |
| Interaction | BTNL2 interactions | 1.38e-04 | 155 | 102 | 6 | int:BTNL2 | |
| Interaction | PCDH12 interactions | 1.81e-04 | 22 | 102 | 3 | int:PCDH12 | |
| Interaction | ZFP41 interactions | 1.99e-04 | 57 | 102 | 4 | int:ZFP41 | |
| Interaction | ZNF444 interactions | 2.03e-04 | 106 | 102 | 5 | int:ZNF444 | |
| Interaction | DAB1 interactions | 2.13e-04 | 107 | 102 | 5 | int:DAB1 | |
| Interaction | LYPD1 interactions | 2.13e-04 | 58 | 102 | 4 | int:LYPD1 | |
| Interaction | RNF123 interactions | SPRY2 LAMB4 FN1 ZNF226 SSPOP DNAH14 IFIH1 CCN4 ADAMTS9 LRP2 C6 FBN3 MEGF10 | 2.64e-04 | 824 | 102 | 13 | int:RNF123 |
| Interaction | NOTCH3 interactions | 2.74e-04 | 113 | 102 | 5 | int:NOTCH3 | |
| Interaction | PLAT interactions | 2.93e-04 | 63 | 102 | 4 | int:PLAT | |
| Interaction | ZBTB3 interactions | 3.11e-04 | 64 | 102 | 4 | int:ZBTB3 | |
| Interaction | CXCL5 interactions | 3.37e-04 | 27 | 102 | 3 | int:CXCL5 | |
| Interaction | NOTCH1 interactions | 3.69e-04 | 345 | 102 | 8 | int:NOTCH1 | |
| Interaction | MMP9 interactions | 3.71e-04 | 67 | 102 | 4 | int:MMP9 | |
| Interaction | ADAMTS9 interactions | 3.75e-04 | 6 | 102 | 2 | int:ADAMTS9 | |
| Interaction | CDH16 interactions | 3.76e-04 | 28 | 102 | 3 | int:CDH16 | |
| Interaction | CDHR4 interactions | 3.93e-04 | 68 | 102 | 4 | int:CDHR4 | |
| Interaction | BAGE2 interactions | 4.39e-04 | 70 | 102 | 4 | int:BAGE2 | |
| Interaction | FIBIN interactions | 4.63e-04 | 71 | 102 | 4 | int:FIBIN | |
| Interaction | ITGA5 interactions | 4.69e-04 | 127 | 102 | 5 | int:ITGA5 | |
| Interaction | THBS1 interactions | 4.69e-04 | 127 | 102 | 5 | int:THBS1 | |
| Interaction | ZSCAN21 interactions | 4.87e-04 | 128 | 102 | 5 | int:ZSCAN21 | |
| Interaction | DYRK1A interactions | 4.88e-04 | 552 | 102 | 10 | int:DYRK1A | |
| Interaction | FBLN1 interactions | 5.04e-04 | 129 | 102 | 5 | int:FBLN1 | |
| Interaction | ZNF664 interactions | 5.10e-04 | 31 | 102 | 3 | int:ZNF664 | |
| Interaction | CAPN10 interactions | 5.61e-04 | 32 | 102 | 3 | int:CAPN10 | |
| Interaction | TNC interactions | 5.61e-04 | 32 | 102 | 3 | int:TNC | |
| Interaction | LILRA5 interactions | 5.61e-04 | 32 | 102 | 3 | int:LILRA5 | |
| Interaction | DNAJB9 interactions | 5.71e-04 | 202 | 102 | 6 | int:DNAJB9 | |
| Interaction | ZNF101 interactions | 6.15e-04 | 33 | 102 | 3 | int:ZNF101 | |
| Interaction | MBD1 interactions | 6.30e-04 | 77 | 102 | 4 | int:MBD1 | |
| Interaction | EGFL7 interactions | 6.30e-04 | 77 | 102 | 4 | int:EGFL7 | |
| Interaction | ST14 interactions | 6.49e-04 | 207 | 102 | 6 | int:ST14 | |
| Interaction | ADAM33 interactions | 6.95e-04 | 79 | 102 | 4 | int:ADAM33 | |
| Interaction | SLC5A1 interactions | 6.96e-04 | 8 | 102 | 2 | int:SLC5A1 | |
| Interaction | SSX6P interactions | 6.96e-04 | 8 | 102 | 2 | int:SSX6P | |
| Interaction | MEPE interactions | 6.96e-04 | 8 | 102 | 2 | int:MEPE | |
| Interaction | LTBP3 interactions | 7.32e-04 | 35 | 102 | 3 | int:LTBP3 | |
| Interaction | SOST interactions | 7.32e-04 | 35 | 102 | 3 | int:SOST | |
| GeneFamily | Latent transforming growth factor beta binding proteins | 3.20e-07 | 4 | 79 | 3 | 628 | |
| GeneFamily | ADAM metallopeptidases with thrombospondin type 1 motif | 1.24e-06 | 19 | 79 | 4 | 50 | |
| GeneFamily | CD molecules|Integrin beta subunits | 6.62e-06 | 9 | 79 | 3 | 1159 | |
| GeneFamily | Laminin subunits | 1.72e-05 | 12 | 79 | 3 | 626 | |
| GeneFamily | Adhesion G protein-coupled receptors, subfamily C|CELSR cadherins | 5.64e-05 | 3 | 79 | 2 | 913 | |
| GeneFamily | Adhesion G protein-coupled receptors, subfamily C|CELSR cadherins | 5.64e-05 | 3 | 79 | 2 | 1189 | |
| GeneFamily | C2-set domain containing|Immunoglobulin like domain containing|Scavenger receptors | 2.18e-04 | 27 | 79 | 3 | 1253 | |
| GeneFamily | Ring finger proteins|Baculoviral IAP repeat containing|Caspase recruitment domain containing | 5.19e-04 | 8 | 79 | 2 | 419 | |
| GeneFamily | C-type lectin domain family | 1.13e-03 | 47 | 79 | 3 | 494 | |
| GeneFamily | Hyalectan proteoglycans|V-set domain containing|Sushi domain containing|C-type lectin domain containing | 1.98e-03 | 57 | 79 | 3 | 1179 | |
| GeneFamily | Acyl-CoA synthetase family | 5.72e-03 | 26 | 79 | 2 | 40 | |
| Coexpression | NABA_MATRISOME | COL4A1 CLEC18A LAMB4 RELN FN1 CLEC18B ADAMTS3 TNC LAMA2 LAMA3 CLEC18C PAPLN ADAMTS5 TECTA ADAM10 SSPOP VWDE F10 SVEP1 CCN4 NELL1 FBLN2 EGF IGFBP7 SEMA5B ADAMTS9 ADAMTS20 CHRDL1 LTBP1 LTBP2 LTBP3 MUC5AC FBN3 MEGF10 | 1.22e-22 | 1026 | 103 | 34 | M5889 |
| Coexpression | NABA_ECM_GLYCOPROTEINS | LAMB4 RELN FN1 TNC LAMA2 LAMA3 PAPLN TECTA SSPOP VWDE SVEP1 CCN4 NELL1 FBLN2 IGFBP7 LTBP1 LTBP2 LTBP3 FBN3 | 2.33e-21 | 196 | 103 | 19 | M3008 |
| Coexpression | NABA_MATRISOME | COL4A1 CLEC18A RELN FN1 CLEC18B ADAMTS3 TNC LAMA2 LAMA3 CLEC18C PAPLN ADAMTS5 TECTA ADAM10 SSPOP VWDE F10 SVEP1 CCN4 NELL1 FBLN2 EGF IGFBP7 SEMA5B ADAMTS9 ADAMTS20 CHRDL1 LTBP1 LTBP2 LTBP3 MUC5AC MEGF10 | 1.05e-20 | 1008 | 103 | 32 | MM17056 |
| Coexpression | NABA_CORE_MATRISOME | COL4A1 LAMB4 RELN FN1 TNC LAMA2 LAMA3 PAPLN TECTA SSPOP VWDE SVEP1 CCN4 NELL1 FBLN2 IGFBP7 LTBP1 LTBP2 LTBP3 FBN3 | 6.17e-20 | 275 | 103 | 20 | M5884 |
| Coexpression | NABA_ECM_GLYCOPROTEINS | RELN FN1 TNC LAMA2 LAMA3 PAPLN TECTA SSPOP VWDE SVEP1 CCN4 NELL1 FBLN2 IGFBP7 LTBP1 LTBP2 LTBP3 | 1.49e-18 | 191 | 103 | 17 | MM17059 |
| Coexpression | NABA_CORE_MATRISOME | COL4A1 RELN FN1 TNC LAMA2 LAMA3 PAPLN TECTA SSPOP VWDE SVEP1 CCN4 NELL1 FBLN2 IGFBP7 LTBP1 LTBP2 LTBP3 | 2.42e-17 | 270 | 103 | 18 | MM17057 |
| Coexpression | WONG_ADULT_TISSUE_STEM_MODULE | COL4A1 RELN FN1 TNC ASH1L LAMA2 TTC3 TENM2 ITGB5 IFIH1 RHOQ FBLN2 IGFBP7 TENM3 ADGRE5 LTBP1 LTBP2 LTBP3 | 4.08e-10 | 721 | 103 | 18 | M1999 |
| Coexpression | HAY_BONE_MARROW_STROMAL | COL4A1 FN1 TNC THSD7B TENM2 ITGB5 SVEP1 TENM4 IGFBP7 ADAMTS9 JAG1 CHRDL1 TNFRSF19 LTBP2 MEGF10 NOTCH3 | 5.19e-08 | 767 | 103 | 16 | M39209 |
| Coexpression | DI_MARTINO_MATRISOME_HIGHLY_PROLIFERATIVE_HNSCC | 6.40e-08 | 27 | 103 | 5 | M47994 | |
| Coexpression | HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION | 9.90e-08 | 200 | 103 | 9 | M5930 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C7_MID_SCHWANN_CELL | 1.08e-07 | 268 | 103 | 10 | M45796 | |
| Coexpression | CHEN_METABOLIC_SYNDROM_NETWORK | COL4A1 ADAMTS3 TNC RUBCNL NAIP LAMA2 ATAD2 ITGB2 F10 SVEP1 STAB1 CCN4 FBLN2 ANKEF1 ADGRE5 LTBP1 LTBP2 LTBP3 ADAP2 | 3.32e-07 | 1242 | 103 | 19 | M1920 |
| Coexpression | MURARO_PANCREAS_MESENCHYMAL_STROMAL_CELL | COL4A1 FN1 TNC LAMA2 ITGB3 ITGB5 CCN4 RHOQ IGFBP7 JAG1 LTBP1 LTBP2 NOTCH2 NOTCH3 | 4.57e-07 | 681 | 103 | 14 | M39175 |
| Coexpression | NABA_BASEMENT_MEMBRANES | 5.01e-07 | 40 | 103 | 5 | M5887 | |
| Coexpression | CHEN_METABOLIC_SYNDROM_NETWORK | COL4A1 ADAMTS3 TNC RUBCNL NAIP LAMA2 ATAD2 ITGB2 F10 SVEP1 STAB1 CCN4 FBLN2 ANKEF1 ADGRE5 LTBP1 LTBP2 LTBP3 ADAP2 | 7.96e-07 | 1316 | 103 | 19 | MM1052 |
| Coexpression | BOQUEST_STEM_CELL_UP | 9.31e-07 | 261 | 103 | 9 | M1834 | |
| Coexpression | NABA_MATRISOME_ASSOCIATED | CLEC18A CLEC18B ADAMTS3 CLEC18C ADAMTS5 ADAM10 F10 EGF SEMA5B ADAMTS9 ADAMTS20 CHRDL1 MUC5AC MEGF10 | 1.18e-06 | 738 | 103 | 14 | MM17058 |
| Coexpression | NABA_MATRISOME_ASSOCIATED | CLEC18A CLEC18B ADAMTS3 CLEC18C ADAMTS5 ADAM10 F10 EGF SEMA5B ADAMTS9 ADAMTS20 CHRDL1 MUC5AC MEGF10 | 1.45e-06 | 751 | 103 | 14 | M5885 |
| Coexpression | VERRECCHIA_EARLY_RESPONSE_TO_TGFB1 | 2.31e-06 | 54 | 103 | 5 | M4737 | |
| Coexpression | MEISSNER_BRAIN_HCP_WITH_H3K4ME3_AND_H3K27ME3 | RELN FN1 ADAMTS5 THSD7B ITGB5 SVEP1 NELL1 FBLN2 TENM4 TC2N IGFBP7 SEMA5B JAG1 LRP2 ADGRE5 ADAP2 | 4.45e-06 | 1074 | 103 | 16 | M1941 |
| Coexpression | NABA_MATRISOME_METASTATIC_LUNG_LYMPH_NODE_METASTASIS | 4.95e-06 | 29 | 103 | 4 | MM17055 | |
| Coexpression | GOTZMANN_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_UP | 7.28e-06 | 68 | 103 | 5 | M1373 | |
| Coexpression | JOHNSTONE_PARVB_TARGETS_3_UP | 8.20e-06 | 433 | 103 | 10 | M2240 | |
| Coexpression | MURARO_PANCREAS_DUCTAL_CELL | SPRY2 SPINT1 LAMA3 ACSS2 ADAM10 ITGB2 ITGB5 STAB1 RHOQ TC2N IGFBP7 ADAMTS9 SQSTM1 JAG1 TRIM8 C6 NOTCH2 | 9.47e-06 | 1276 | 103 | 17 | M39173 |
| Coexpression | GOTZMANN_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_UP | 9.65e-06 | 72 | 103 | 5 | MM1131 | |
| Coexpression | NABA_MATRISOME_PRIMARY_METASTATIC_LUNG_TUMOR | 1.07e-05 | 35 | 103 | 4 | MM17054 | |
| Coexpression | RUBENSTEIN_SKELETAL_MUSCLE_FBN1_FAP_CELLS | 1.91e-05 | 289 | 103 | 8 | M41750 | |
| Coexpression | NABA_MATRISOME_HIGHLY_METASTATIC_BREAST_CANCER | 2.04e-05 | 41 | 103 | 4 | M47988 | |
| Coexpression | PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP | 2.04e-05 | 211 | 103 | 7 | M12225 | |
| Coexpression | HEBERT_MATRISOME_TNBC_LIVER_METASTASIS | 2.08e-05 | 14 | 103 | 3 | M48002 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HRGL2A | SPRY2 TNC ITGB5 CELSR1 ZNF497 TC2N SEMA5B JAG1 LRP2 LTBP1 NOTCH2 | 2.45e-05 | 600 | 103 | 11 | M39055 |
| Coexpression | FUKUSHIMA_TNFSF11_TARGETS | 3.18e-05 | 16 | 103 | 3 | MM1296 | |
| Coexpression | FUKUSHIMA_TNFSF11_TARGETS | 3.18e-05 | 16 | 103 | 3 | M2207 | |
| Coexpression | DI_MARTINO_MATRISOME_HIGHLY_PROLIFERATIVE_HNSCC_TUMOR_CELL_DERIVED | 3.85e-05 | 17 | 103 | 3 | M47995 | |
| Coexpression | THUM_MIR21_TARGETS_HEART_DISEASE_UP | 4.61e-05 | 18 | 103 | 3 | MM1241 | |
| Coexpression | THUM_MIR21_TARGETS_HEART_DISEASE_UP | 4.61e-05 | 18 | 103 | 3 | M13796 | |
| Coexpression | BRAUNE_GEIST_20_GENE_NOTCH_SIG_BREAST_CANCER | 6.40e-05 | 20 | 103 | 3 | M48357 | |
| Coexpression | NABA_MATRISOME_BLEO_FIBROTIC_LUNG | 6.40e-05 | 20 | 103 | 3 | MM17053 | |
| Coexpression | CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_UP | 6.59e-05 | 174 | 103 | 6 | M2038 | |
| Coexpression | PEREZ_TP53_TARGETS | LAMB4 ZNF658 ZNF570 ASH1L CNTNAP3 ADAMTS5 IFIH1 CCN4 CELSR2 TRIM8 LTBP3 BRD1 MUC5AC MEGF10 ADAP2 | 7.00e-05 | 1201 | 103 | 15 | M4391 |
| Coexpression | NABA_MATRISOME_HGSOC_OMENTAL_METASTASIS | 8.67e-05 | 59 | 103 | 4 | M47993 | |
| Coexpression | NABA_MATRISOME_PRIMARY_METASTATIC_COLORECTAL_TUMOR | 8.67e-05 | 59 | 103 | 4 | M47989 | |
| Coexpression | WU_CELL_MIGRATION | 8.71e-05 | 183 | 103 | 6 | M2001 | |
| Coexpression | GRUETZMANN_PANCREATIC_CANCER_UP | 8.79e-05 | 359 | 103 | 8 | M15193 | |
| Coexpression | FOROUTAN_PRODRANK_TGFB_EMT_UP | 9.24e-05 | 185 | 103 | 6 | M42503 | |
| Coexpression | FOROUTAN_INTEGRATED_TGFB_EMT_UP | 1.13e-04 | 120 | 103 | 5 | M42505 | |
| Coexpression | GSE21927_SPLEEN_VS_TUMOR_MONOCYTE_BALBC_UP | 1.13e-04 | 192 | 103 | 6 | M7579 | |
| Coexpression | FOROUTAN_TGFB_EMT_UP | 1.13e-04 | 192 | 103 | 6 | M42501 | |
| Coexpression | GSE21360_PRIMARY_VS_QUATERNARY_MEMORY_CD8_TCELL_DN | 1.34e-04 | 198 | 103 | 6 | M7610 | |
| Coexpression | GSE3982_EOSINOPHIL_VS_BCELL_UP | 1.38e-04 | 199 | 103 | 6 | M5406 | |
| Coexpression | GSE19772_HCMV_INFL_VS_HCMV_INF_MONOCYTES_AND_PI3K_INHIBITION_UP | 1.42e-04 | 200 | 103 | 6 | M7283 | |
| Coexpression | GSE46143_CTRL_VS_LMP2A_TRANSDUCED_CD10_POS_GC_BCELL_DN | 1.42e-04 | 200 | 103 | 6 | M9773 | |
| Coexpression | MARTINEZ_RB1_AND_TP53_TARGETS_DN | SPINT1 LAMA2 TENM2 FBLN2 TENM4 TC2N CELSR2 TNFRSF19 LTBP1 LTBP2 | 1.47e-04 | 610 | 103 | 10 | M3854 |
| Coexpression | HARALAMBIEVA_PBMC_M_M_R_II_AGE_11_22YO_VACCINATED_VS_UNVACCINATED_7YR_DN | FN1 DSC1 NAIP TTC3 ITGB2 ITGB5 STAB1 CELSR1 TENM4 LTBP2 NOTCH3 | 1.59e-04 | 740 | 103 | 11 | M41202 |
| Coexpression | TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_DN | 1.66e-04 | 206 | 103 | 6 | M14134 | |
| Coexpression | DESCARTES_FETAL_THYMUS_VASCULAR_ENDOTHELIAL_CELLS | 1.71e-04 | 131 | 103 | 5 | M40316 | |
| Coexpression | SESTO_RESPONSE_TO_UV_C8 | 1.79e-04 | 71 | 103 | 4 | M2948 | |
| Coexpression | COLIN_PILOCYTIC_ASTROCYTOMA_VS_GLIOBLASTOMA_DN | 1.80e-04 | 28 | 103 | 3 | M14859 | |
| Coexpression | SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP | 1.97e-04 | 404 | 103 | 8 | M19488 | |
| Coexpression | AIZARANI_LIVER_C9_LSECS_1 | 2.02e-04 | 304 | 103 | 7 | M39113 | |
| Coexpression | LEE_METASTASIS_AND_ALTERNATIVE_SPLICING_UP | 2.09e-04 | 74 | 103 | 4 | M515 | |
| Coexpression | GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_UP | 2.26e-04 | 218 | 103 | 6 | M1099 | |
| Coexpression | MARTINEZ_RB1_AND_TP53_TARGETS_DN | SPINT1 LAMA2 TENM2 FBLN2 TENM4 TC2N CELSR2 TNFRSF19 LTBP1 LTBP2 | 2.44e-04 | 650 | 103 | 10 | MM1042 |
| Coexpression | MODY_HIPPOCAMPUS_NEONATAL | 2.69e-04 | 32 | 103 | 3 | MM657 | |
| Coexpression | HALLMARK_NOTCH_SIGNALING | 2.69e-04 | 32 | 103 | 3 | M5903 | |
| Coexpression | DESCARTES_FETAL_KIDNEY_STROMAL_CELLS | 2.83e-04 | 146 | 103 | 5 | M40222 | |
| Coexpression | BOQUEST_STEM_CELL_CULTURED_VS_FRESH_UP | 2.87e-04 | 427 | 103 | 8 | M17923 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HPERIC | COL4A1 FN1 LAMA2 ITGB5 SVEP1 CCN4 IGFBP7 JAG1 NOTCH2 NOTCH3 ADAP2 | 2.95e-04 | 795 | 103 | 11 | M39050 |
| Coexpression | MODY_HIPPOCAMPUS_NEONATAL | 2.95e-04 | 33 | 103 | 3 | M7409 | |
| Coexpression | MENON_FETAL_KIDNEY_3_STROMAL_CELLS | 2.97e-04 | 81 | 103 | 4 | M39253 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HRGL2C | 3.03e-04 | 325 | 103 | 7 | M39053 | |
| Coexpression | BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_AND_PAX3 | 3.17e-04 | 7 | 103 | 2 | M18597 | |
| Coexpression | GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_UP | 3.38e-04 | 235 | 103 | 6 | MM978 | |
| Coexpression | ONDER_CDH1_SIGNALING_VIA_CTNNB1 | 3.41e-04 | 84 | 103 | 4 | M15484 | |
| Coexpression | CLASPER_LYMPHATIC_VESSELS_DURING_METASTASIS_DN | 3.52e-04 | 35 | 103 | 3 | M11788 | |
| Coexpression | NABA_ECM_REGULATORS | 3.61e-04 | 238 | 103 | 6 | M3468 | |
| Coexpression | LAKE_ADULT_KIDNEY_C28_INTERSTITIUM | 3.73e-04 | 86 | 103 | 4 | M39247 | |
| Coexpression | CLASPER_LYMPHATIC_VESSELS_DURING_METASTASIS_DN | 3.83e-04 | 36 | 103 | 3 | MM1212 | |
| Coexpression | NABA_ECM_REGULATORS | 3.95e-04 | 242 | 103 | 6 | MM17062 | |
| Coexpression | NABA_ECM_AFFILIATED | 4.06e-04 | 158 | 103 | 5 | MM17063 | |
| Coexpression | BRUNEAU_HEART_GREAT_VESSELS_AND_VALVULOGENESIS | 4.22e-04 | 8 | 103 | 2 | M9884 | |
| Coexpression | LIU_VAV3_PROSTATE_CARCINOGENESIS_UP | 4.25e-04 | 89 | 103 | 4 | M215 | |
| Coexpression | MA_RAT_AGING_DN | 4.43e-04 | 161 | 103 | 5 | M46419 | |
| Coexpression | CARRILLOREIXACH_HEPATOBLASTOMA_VS_NORMAL_HYPOMETHYLATED_AND_UP | 4.56e-04 | 162 | 103 | 5 | M45037 | |
| Coexpression | ESC_V6.5_UP_EARLY.V1_DN | 4.69e-04 | 163 | 103 | 5 | M2769 | |
| Coexpression | VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP | 4.69e-04 | 163 | 103 | 5 | M12112 | |
| Coexpression | SESTO_RESPONSE_TO_UV_C6 | 4.86e-04 | 39 | 103 | 3 | M4229 | |
| Coexpression | DESCARTES_FETAL_EYE_ASTROCYTES | 4.86e-04 | 39 | 103 | 3 | M40188 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C3_OMD_POS_ENDOTHELIAL_CELL | 5.13e-04 | 355 | 103 | 7 | M45758 | |
| Coexpression | KAAB_HEART_ATRIUM_VS_VENTRICLE_UP | 5.31e-04 | 256 | 103 | 6 | M10952 | |
| Coexpression | MA_RAT_AGING_DN | 5.67e-04 | 170 | 103 | 5 | MM16097 | |
| Coexpression | NABA_ECM_AFFILIATED | 5.67e-04 | 170 | 103 | 5 | M5880 | |
| Coexpression | LIM_MAMMARY_STEM_CELL_UP | 6.13e-04 | 479 | 103 | 8 | M2573 | |
| Coexpression | DELACROIX_RARG_BOUND_MEF | 6.15e-04 | 366 | 103 | 7 | M2461 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C0_MESENCHYMAL_3_CELL | 6.30e-04 | 174 | 103 | 5 | M45676 | |
| Coexpression | LIM_MAMMARY_STEM_CELL_UP | 6.47e-04 | 483 | 103 | 8 | MM1082 | |
| Coexpression | SMID_BREAST_CANCER_NORMAL_LIKE_UP | 6.64e-04 | 485 | 103 | 8 | M8513 | |
| Coexpression | VANHARANTA_UTERINE_FIBROID_UP | 6.94e-04 | 44 | 103 | 3 | M18274 | |
| Coexpression | VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP | 6.99e-04 | 178 | 103 | 5 | M17079 | |
| Coexpression | RUBENSTEIN_SKELETAL_MUSCLE_FAP_CELLS | 7.16e-04 | 179 | 103 | 5 | M41745 | |
| CoexpressionAtlas | Stromal Cells, Fi.MTS15+.Th, CD45- PDGFRa+ MTS15+, Thymus, avg-3 | COL4A1 SPRY2 FN1 TNC LAMA2 ADAMTS5 ITGB5 SVEP1 FBLN2 IGFBP7 TENM3 ADAMTS9 JAG1 LTBP1 CSMD1 RECK ADAP2 | 4.01e-11 | 445 | 102 | 17 | GSM777043_500 |
| CoexpressionAtlas | Stromal Cells, FRC.MLN, gp38+ CD31- CD140a+, Lymph Node, avg-5 | COL4A1 SPRY2 FN1 TNC LAMA2 ADAMTS5 ITGB5 SVEP1 IGFBP7 TENM3 CHRDL1 LTBP1 LTBP3 CSMD1 RECK NOTCH3 | 7.53e-10 | 466 | 102 | 16 | GSM777050_500 |
| CoexpressionAtlas | ECTO blastocyst_vs_ECTO bone marrow-Confounder_removed-fold2.0_adjp0.05 | CLEC18A RELN FN1 CLEC18B CLEC18C TENM4 IGFBP7 TNFRSF19 LTBP1 | 2.98e-08 | 143 | 102 | 9 | PCBC_ratio_ECTO blastocyst_vs_ECTO bone marrow_cfr-2X-p05 |
| CoexpressionAtlas | Stromal Cells, FRC.SLN, gp38+ CD31- CD140a+, Lymph Node, avg-4 | COL4A1 SPRY2 FN1 TNC ADAMTS5 ITGB5 SVEP1 IGFBP7 TENM3 JAG1 CHRDL1 LTBP2 CSMD1 NOTCH3 | 3.76e-08 | 455 | 102 | 14 | GSM777055_500 |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitLeydig_MafB_top-relative-expression-ranked_1000 | COL4A1 ADAMTS3 TNC LAMA2 ADAMTS5 ATAD2 ITGB5 SVEP1 CCN4 FBLN2 TENM4 IGFBP7 TENM3 ADAMTS9 JAG1 RECK NOTCH2 | 1.41e-07 | 768 | 102 | 17 | gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_1000 |
| CoexpressionAtlas | Stromal Cells, LEC.SLN, gp38+ CD31+, Lymph Node, avg-4 | COL4A1 RELN STAB2 FN1 TNC ADAMTS5 STAB1 TC2N IGFBP7 ADAMTS9 JAG1 LTBP1 LTBP2 | 2.47e-07 | 450 | 102 | 13 | GSM777063_500 |
| CoexpressionAtlas | ECTO blastocyst_vs_ECTO cord blood-Confounder_removed-fold2.0_adjp0.05 | 3.26e-07 | 189 | 102 | 9 | PCBC_ratio_ECTO blastocyst_vs_ECTO cord blood_cfr-2X-p05 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitTestis_Sma_top-relative-expression-ranked_1000 | COL4A1 FN1 TNC LAMA2 ADAMTS5 THSD7B ITGB5 SVEP1 CCN4 TENM4 IGFBP7 TENM3 ADAMTS9 JAG1 RECK NOTCH2 | 8.91e-07 | 777 | 102 | 16 | gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_1000 |
| CoexpressionAtlas | Stromal Cells, Fi.Sk, gp38+ CD140a+, Skin, avg-4 | FN1 TNC LAMA2 ADAMTS5 ITGB5 SVEP1 FBLN2 IGFBP7 TENM3 CHRDL1 LTBP1 RECK | 1.26e-06 | 437 | 102 | 12 | GSM777046_500 |
| CoexpressionAtlas | ECTO blastocyst_vs_ECTO fibroblast-Confounder_removed-fold2.0_adjp0.05 | 1.63e-06 | 118 | 102 | 7 | PCBC_ratio_ECTO blastocyst_vs_ECTO fibroblast_cfr-2X-p05 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#1_top-relative-expression-ranked_1000 | 1.83e-06 | 120 | 102 | 7 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000_k1 | |
| CoexpressionAtlas | Stromal Cells, St.31-38-44-.SLN, CD45- gp38- CD31- CD44-, Lymph Node, avg-2 | COL4A1 FN1 TNC LAMA2 ADAMTS5 ITGB5 SVEP1 IGFBP7 JAG1 CHRDL1 NOTCH3 ADAP2 | 1.83e-06 | 453 | 102 | 12 | GSM777067_500 |
| CoexpressionAtlas | AravindRamakr_EmbryoidBody-LF_top-relative-expression-ranked_1000 | CLEC18A RELN FN1 CLEC18B TNC CLEC18C ITGB3 SVEP1 CCN4 NELL1 TENM4 CNTNAP4 LRP2 ADAMTS20 TNFRSF19 FBN3 MEGF10 | 4.09e-06 | 981 | 102 | 17 | Arv_EB-LF_1000 |
| CoexpressionAtlas | ratio_EmbryoidBody_vs_StemCell_top-relative-expression-ranked_2500_k-means-cluster#3 | COL4A1 CLEC18A FN1 CLEC18B CLEC18C ADAMTS5 TTC3 SSPOP SVEP1 CCN4 NELL1 FBLN2 TENM4 ADAMTS9 CNTNAP4 LRP2 TNFRSF19 LTBP2 | 4.23e-06 | 1094 | 102 | 18 | ratio_EB_vs_SC_2500_K3 |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_EmbryoidBody_fromBlastocyst-derived-humanEmbryonicStemCells_top-relative-expression-ranked_1000 | CLEC18A RELN CLEC18B CLEC18C THSD7B SVEP1 CCN4 NELL1 TENM4 SEMA5B CNTNAP4 LRP2 ADAMTS20 TNFRSF19 CSMD1 FBN3 MEGF10 | 4.75e-06 | 992 | 102 | 17 | PCBC_EB_blastocyst_1000 |
| CoexpressionAtlas | ratio_EmbryoidBody_vs_StemCell_top-relative-expression-ranked_500 | RELN FN1 CLEC18B TNC ITGB3 SVEP1 CCN4 NELL1 IGFBP7 ADAMTS9 CNTNAP4 TNFRSF19 | 4.84e-06 | 498 | 102 | 12 | PCBC_ratio_EB_vs_SC_500 |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_EmbryoidBody_top-relative-expression-ranked_1000 | CLEC18A RELN FN1 CLEC18B CLEC18C SVEP1 CCN4 NELL1 TENM4 SEMA5B CNTNAP4 LRP2 ADAMTS20 TNFRSF19 CSMD1 FBN3 MEGF10 | 4.87e-06 | 994 | 102 | 17 | PCBC_EB_1000 |
| CoexpressionAtlas | dev lower uro neuro_e15.5_PelvicGanglion_Sox10_k-means-cluster#2_top-relative-expression-ranked_1000 | 5.07e-06 | 91 | 102 | 6 | gudmap_dev lower uro neuro_e15.5_PelvicGanglion_Sox10_k2_1000 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitTestis_Sma_top-relative-expression-ranked_1000 | FN1 ADAMTS3 TNC LAMA2 ADAMTS5 ITGB5 SVEP1 CCN4 FBLN2 TENM4 IGFBP7 TENM3 ADAMTS9 RECK NOTCH2 | 5.69e-06 | 793 | 102 | 15 | gudmap_dev gonad_e12.5_M_InterstitTestis_Sma_1000 |
| CoexpressionAtlas | AravindRamakr_EmbryoidBody-LF_top-relative-expression-ranked_1000_k-means-cluster#4 | CLEC18A CLEC18B CLEC18C CCN4 NELL1 TENM4 CNTNAP4 LRP2 ADAMTS20 TNFRSF19 FBN3 | 7.53e-06 | 433 | 102 | 11 | Arv_EB-LF_1000_K4 |
| CoexpressionAtlas | Endoderm Differentiated Cells_vs_Pluripotent Stem Cells-Confounder_removed-fold2.0_adjp0.05 | COL4A1 SPRY2 FN1 TNC ZSWIM5 TTC3 ITGB5 TDRD7 FBLN2 TENM4 LTBP1 FUT8 FBN3 | 7.84e-06 | 615 | 102 | 13 | PCBC_ratio_DE_vs_SC_cfr-2X-p05 |
| CoexpressionAtlas | ECTO blastocyst_vs_ECTO amniotic fluid MSC-Confounder_removed-fold2.0_adjp0.05 | CLEC18A RELN CLEC18B SPINT1 TNC CLEC18C TENM4 TNFRSF19 LTBP1 | 8.32e-06 | 280 | 102 | 9 | PCBC_ratio_ECTO blastocyst_vs_ECTO amniotic fluid MSC_cfr-2X-p05 |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_top-relative-expression-ranked_500 | COL4A1 FN1 ADAMTS3 LAMA2 ADAMTS5 SVEP1 IGFBP7 ADAMTS9 JAG1 NOTCH2 | 8.40e-06 | 356 | 102 | 10 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_500 |
| CoexpressionAtlas | Stromal Cells, LEC.MLN, gp38+ CD31+, Lymph Node, avg-4 | COL4A1 RELN STAB2 FN1 TNC STAB1 IGFBP7 ADAMTS9 JAG1 LTBP1 LTBP2 | 8.57e-06 | 439 | 102 | 11 | GSM777059_500 |
| CoexpressionAtlas | SC blastocyst_vs_SC-LF blastocyst-Confounder_removed-fold2.0_adjp0.05 | 9.73e-06 | 216 | 102 | 8 | PCBC_ratio_SC blastocyst_vs_SC-LF blastocyst_cfr-2X-p05 | |
| CoexpressionAtlas | dev lower uro neuro_e15.5_PelvicGanglion_Sox10_top-relative-expression-ranked_1000 | FN1 ADAMTS3 TNC CNTNAP3 LAMA2 DGKB ADAMTS5 SVEP1 NELL1 IGFBP7 TENM3 ADAMTS9 CNTNAP4 LTBP1 | 1.10e-05 | 734 | 102 | 14 | gudmap_dev lower uro neuro_e15.5_PelvicGanglion_Sox10_1000 |
| CoexpressionAtlas | AravindRamakr_EmbryoidBody-LF_top-relative-expression-ranked_2500_k-means-cluster#2 | COL4A1 CLEC18A FN1 CLEC18B CLEC18C SVEP1 CCN4 NELL1 TENM4 IGFBP7 CNTNAP4 LRP2 ADAMTS20 TNFRSF19 LTBP2 FBN3 | 1.18e-05 | 951 | 102 | 16 | Arv_EB-LF_2500_K2 |
| CoexpressionAtlas | kidney_P0_JuxtaGlom_Ren1_k-means-cluster#3_top-relative-expression-ranked_1000 | 1.20e-05 | 293 | 102 | 9 | gudmap_kidney_P0_JuxtaGlom_Ren1_k3_1000 | |
| CoexpressionAtlas | kidney_P3_CapMes_Crym_k-means-cluster#4_top-relative-expression-ranked_200 | 1.52e-05 | 65 | 102 | 5 | gudmap_kidney_P3_CapMes_Crym_k4_200 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitLeydig_MafB_k-means-cluster#1_top-relative-expression-ranked_1000 | 1.87e-05 | 310 | 102 | 9 | gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_k1_1000 | |
| CoexpressionAtlas | Ectoderm Differentiated Cells_vs_Pluripotent Stem Cells-Confounder_removed-fold2.0_adjp0.05 | CLEC18A CLEC18B TNC CNTNAP3 CLEC18C AHCYL2 ZNF226 TTC3 CELSR1 EGF CELSR2 IGFBP7 ADAMTS9 JAG1 LRP2 LTBP1 LTBP2 FUT8 FBN3 NOTCH2 | 1.88e-05 | 1466 | 102 | 20 | PCBC_ratio_ECTO_vs_SC_cfr-2X-p05 |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_top-relative-expression-ranked_1000 | COL4A1 FN1 ADAMTS3 LAMA2 ADAMTS5 ITGB5 SVEP1 TENM4 IGFBP7 TENM3 ADAMTS9 JAG1 RECK NOTCH2 | 1.95e-05 | 773 | 102 | 14 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_1000 |
| CoexpressionAtlas | ratio_EmbryoidBody_vs_StemCell_top-relative-expression-ranked_1000 | CLEC18A RELN FN1 CLEC18B TNC CLEC18C ITGB3 TENM2 SVEP1 CCN4 NELL1 IGFBP7 ADAMTS9 CNTNAP4 TNFRSF19 LTBP2 | 2.03e-05 | 994 | 102 | 16 | PCBC_ratio_EB_vs_SC_1000 |
| CoexpressionAtlas | facebase_RNAseq_e14.5_palate_poster_proximal_ERK2_WT_2500_K3 | 2.08e-05 | 240 | 102 | 8 | facebase_RNAseq_e14.5_palate_poster_proximal_ERK2_WT_2500_K3 | |
| CoexpressionAtlas | kidney_P4_CapMesRenVes_Crym_top-relative-expression-ranked_500 | CLEC18A SPINT1 TENM4 CELSR2 IGFBP7 ADAMTS9 JAG1 LRP2 LTBP1 NOTCH2 | 2.20e-05 | 398 | 102 | 10 | gudmap_kidney_P4_CapMesRenVes_Crym_500 |
| CoexpressionAtlas | kidney_P4_CapMesRenVes_Crym_top-relative-expression-ranked_1000 | CLEC18A SPINT1 TNC ACSL1 CELSR1 TENM4 CELSR2 IGFBP7 TENM3 ADAMTS9 JAG1 LRP2 LTBP1 NOTCH2 | 2.25e-05 | 783 | 102 | 14 | gudmap_kidney_P4_CapMesRenVes_Crym_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_500 | SPRY2 AHCYL1 SPINT1 ZSWIM5 CELSR1 CELSR2 SEMA5B JAG1 LRP2 CHRDL1 TNFRSF19 | 2.66e-05 | 496 | 102 | 11 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_500 |
| CoexpressionAtlas | Ectoderm Differentiated Cells-reprogram_NA_vs_Ectoderm Differentiated Cells-reprogram_OSKM-L-Confounder_removed-fold2.0_adjp0.05 | 2.69e-05 | 73 | 102 | 5 | PCBC_ratio_ECTO_from-ESC_vs_ECTO_from-OSKM-L_cfr-2X-p05 | |
| CoexpressionAtlas | Ectoderm Differentiated Cells-method_NA_vs_Ectoderm Differentiated Cells-method_mRNA-Confounder_removed-fold2.0_adjp0.05 | 2.69e-05 | 73 | 102 | 5 | PCBC_ratio_ECTO_from-ESC_vs_ECTO_from-mRNA_cfr-2X-p05 | |
| CoexpressionAtlas | kidney_P0_JuxtaGlom_Ren1_top-relative-expression-ranked_1000 | RELN FN1 ADAMTS3 DGKB ITGB3 ACSL1 RHOQ IGFBP7 ADAMTS9 JAG1 LRP2 LTBP1 RECK NOTCH2 NOTCH3 | 2.70e-05 | 905 | 102 | 15 | gudmap_kidney_P0_JuxtaGlom_Ren1_1000 |
| CoexpressionAtlas | Mesoderm Day 5_vs_Pluripotent Stem Cells-Confounder_removed-fold2.0_adjp0.05 | COL4A1 SPRY2 RELN FN1 TNC ZSWIM5 TTC3 ITGB5 TDRD7 CELSR1 FBLN2 EGF ADAMTS9 TNFRSF19 LTBP1 FUT8 FBN3 | 3.32e-05 | 1153 | 102 | 17 | PCBC_ratio_MESO-5_vs_SC_cfr-2X-p05 |
| CoexpressionAtlas | Ectoderm Differentiated Cells-reprogram_NA_vs_Ectoderm Differentiated Cells-reprogram_OSKM - NLT-Confounder_removed-fold2.0_adjp0.05 | 3.70e-05 | 78 | 102 | 5 | PCBC_ratio_ECTO_from-ESC_vs_ECTO_from-OSKM - NLT_cfr-2X-p05 | |
| CoexpressionAtlas | placenta | COL4A1 ERVV-2 FN1 LAMA2 ADAMTS5 ERVMER34-1 SVEP1 TENM3 ADAMTS9 | 4.72e-05 | 349 | 102 | 9 | placenta |
| CoexpressionAtlas | kidney_P0_JuxtaGlom_Ren1_top-relative-expression-ranked_100 | 6.27e-05 | 87 | 102 | 5 | gudmap_kidney_P0_JuxtaGlom_Ren1_100 | |
| CoexpressionAtlas | Mesoderm Day 5-reprogram_OSKM-L_vs_Mesoderm Day 5-reprogram_NA-Confounder_removed-fold2.0_adjp0.05 | 6.37e-05 | 281 | 102 | 8 | PCBC_ratio_MESO-5_from-OSKM-L_vs_MESO-5_from-ESC_cfr-2X-p05 | |
| CoexpressionAtlas | Mesoderm Day 5-method_mRNA_vs_Mesoderm Day 5-method_NA-Confounder_removed-fold2.0_adjp0.05 | 6.37e-05 | 281 | 102 | 8 | PCBC_ratio_MESO-5_from-mRNA_vs_MESO-5_from-ESC_cfr-2X-p05 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Non-Floor Plate Neural Epithelium_top-relative-expression-ranked_1000 | ADAMTS3 SPINT1 TNC ZSWIM5 THSD7B ACSS2 TENM2 CCN4 FBLN2 CELSR2 IGFBP7 SEMA5B LRP2 CHRDL1 LTBP3 | 6.40e-05 | 976 | 102 | 15 | Facebase_RNAseq_e8.5_Non-Floor Plate Neural Epithelium_1000 |
| CoexpressionAtlas | ECTO blastocyst_vs_ECTO UCB CD34+Z-Confounder_removed-fold2.0_adjp0.05 | 6.86e-05 | 284 | 102 | 8 | PCBC_ratio_ECTO blastocyst_vs_ECTO UCB CD34+Z_cfr-2X-p05 | |
| CoexpressionAtlas | MESO-30 blastocyst_vs_MESO-30 amniotic fluid MSC-Confounder_removed-fold2.0_adjp0.05 | COL4A1 FN1 SPINT1 TNC LAMA3 ITGB5 CCN4 TC2N IGFBP7 ADAMTS9 LTBP2 C6 FUT8 | 7.19e-05 | 761 | 102 | 13 | PCBC_ratio_MESO-30 blastocyst_vs_MESO-30 amniotic fluid MSC_cfr-2X-p05 |
| CoexpressionAtlas | kidney_adult_RenalCapsule_k-means-cluster#2_top-relative-expression-ranked_1000 | 7.25e-05 | 369 | 102 | 9 | gudmap_kidney_adult_RenalCapsule_k2_1000 | |
| CoexpressionAtlas | Stromal Cells, LEC.MLN, gp38+ CD31+, Lymph Node, avg-4 | 7.77e-05 | 91 | 102 | 5 | GSM777059_100 | |
| CoexpressionAtlas | kidney_adult_RenalCapsule_top-relative-expression-ranked_1000 | ADAMTS3 CNTNAP3 LAMA2 ADAMTS5 SVEP1 IFIH1 FBLN2 IGFBP7 LRP2 CHRDL1 LTBP2 LTBP3 RECK | 8.98e-05 | 778 | 102 | 13 | gudmap_kidney_adult_RenalCapsule_1000 |
| CoexpressionAtlas | Stromal Cells, LEC.SLN, gp38+ CD31+, Lymph Node, avg-4 | 1.00e-04 | 96 | 102 | 5 | GSM777063_100 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_100 | 1.10e-04 | 98 | 102 | 5 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_100 | |
| CoexpressionAtlas | ratio_induced-Ectoderm_vs_StemCell_top-relative-expression-ranked_100 | 1.22e-04 | 100 | 102 | 5 | PCBC_ratio_ECTO_vs_SC_100 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonMes_Sma_k-means-cluster#3_top-relative-expression-ranked_1000 | 1.29e-04 | 311 | 102 | 8 | gudmap_dev gonad_e11.5_M_GonMes_Sma_k3_1000 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_EmbryoidBody_top-relative-expression-ranked_500 | CLEC18A RELN CLEC18B SVEP1 CCN4 NELL1 CNTNAP4 LRP2 ADAMTS20 FBN3 | 1.38e-04 | 496 | 102 | 10 | PCBC_EB_500 |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_EmbryoidBody_fromBlastocyst-derived-humanEmbryonicStemCells_top-relative-expression-ranked_500 | CLEC18A RELN CLEC18B CLEC18C SVEP1 CCN4 NELL1 CNTNAP4 LRP2 FBN3 | 1.38e-04 | 496 | 102 | 10 | PCBC_EB_blastocyst_500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_2500_k-means-cluster#1 | 1.44e-04 | 236 | 102 | 7 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_2500_K1 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_top-relative-expression-ranked_1000 | AHCYL1 TNC ZSWIM5 ASH1L DGKB XIAP ADAMTS5 THSD7B TTC3 TENM2 CNTNAP4 ADAMTS20 MEGF10 | 1.48e-04 | 818 | 102 | 13 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_1000 |
| CoexpressionAtlas | Mesoderm Day 30-reprogram_OSKM - NLT_vs_Mesoderm Day 30-reprogram_NA-Confounder_removed-fold2.0_adjp0.05 | 1.50e-04 | 501 | 102 | 10 | PCBC_ratio_MESO-30_from-OSKM - NLT_vs_MESO-30_from-ESC_cfr-2X-p05 | |
| CoexpressionAtlas | MESO-30 fibroblast_vs_MESO-30 blastocyst-Confounder_removed-fold2.0_adjp0.05 | 1.50e-04 | 501 | 102 | 10 | PCBC_ratio_MESO-30 fibroblast_vs_MESO-30 blastocyst_cfr-2X-p05 | |
| CoexpressionAtlas | Mesoderm Day 30-method_plasmid_vs_Mesoderm Day 30-method_NA-Confounder_removed-fold2.0_adjp0.05 | 1.50e-04 | 501 | 102 | 10 | PCBC_ratio_MESO-30_from-plasmid_vs_MESO-30_from-ESC_cfr-2X-p05 | |
| CoexpressionAtlas | kidney_P3_CapMes_Crym_top-relative-expression-ranked_200 | 1.51e-04 | 166 | 102 | 6 | gudmap_kidney_P3_CapMes_Crym_200 | |
| CoexpressionAtlas | ratio_induced-DefinitiveEndoderm_vs_StemCell_top-relative-expression-ranked_500_k-means-cluster#2 | 1.72e-04 | 170 | 102 | 6 | ratio_DE_vs_SC_500_K2 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#3_top-relative-expression-ranked_1000 | 1.73e-04 | 243 | 102 | 7 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_1000_k3 | |
| CoexpressionAtlas | dev gonad_e11.5_F_GonMes_Sma_k-means-cluster#4_top-relative-expression-ranked_1000 | 1.81e-04 | 327 | 102 | 8 | gudmap_dev gonad_e11.5_F_GonMes_Sma_k4_1000 | |
| CoexpressionAtlas | kidney_adult_RenalCapsule_top-relative-expression-ranked_200 | 1.95e-04 | 174 | 102 | 6 | gudmap_kidney_adult_RenalCapsule_200 | |
| CoexpressionAtlas | kidney_P0_JuxtaGlom_Ren1_top-relative-expression-ranked_200 | 2.14e-04 | 177 | 102 | 6 | gudmap_kidney_P0_JuxtaGlom_Ren1_200 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Olfactory Placode_top-relative-expression-ranked_1000 | SPINT1 TNC ZSWIM5 THSD7B ACSS2 TENM2 CELSR1 FBLN2 CELSR2 IGFBP7 ADAMTS9 LRP2 CHRDL1 LTBP3 | 2.27e-04 | 973 | 102 | 14 | Facebase_RNAseq_e9.5_Olfactory Placode_1000 |
| CoexpressionAtlas | dev gonad_e12.5_M_SertoliCell_Sox9_k-means-cluster#1_top-relative-expression-ranked_100 | 2.29e-04 | 25 | 102 | 3 | gudmap_dev gonad_e12.5_M_SertoliCell_Sox9_k1_100 | |
| CoexpressionAtlas | ratio_induced-DefinitiveEndoderm_vs_StemCell_top-relative-expression-ranked_1000 | RELN FN1 TNC ZSWIM5 ADAMTS5 TTC3 ITGB3 TENM2 ITGB5 TDRD7 TENM4 EGF IGFBP7 ADAMTS9 | 2.35e-04 | 976 | 102 | 14 | PCBC_ratio_DE_vs_SC_1000 |
| CoexpressionAtlas | ratio_induced-Mesoderm_vs_StemCell_top-relative-expression-ranked_1000 | COL4A1 RELN FN1 TNC TTC3 SSPOP F10 TDRD7 FBLN2 TENM4 ADAMTS9 LTBP1 LTBP2 LTBP3 | 2.50e-04 | 982 | 102 | 14 | PCBC_ratio_MESO-5_vs_SC_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_1000 | SPINT1 TNC ZSWIM5 THSD7B ACSS2 TENM2 CELSR1 FBLN2 CELSR2 IGFBP7 SEMA5B ADAMTS9 LRP2 LTBP3 | 2.55e-04 | 984 | 102 | 14 | Facebase_RNAseq_e10.5_Olfactory Pit_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#4_top-relative-expression-ranked_500 | 2.56e-04 | 64 | 102 | 4 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_500_k4 | |
| CoexpressionAtlas | JC_fibro_top-relative-expression-ranked_1000 | RAPSN FN1 ADAMTS5 ITGB3 F10 SVEP1 IFIH1 CCN4 FBLN2 IGFBP7 SQSTM1 DLK2 LTBP2 RECK | 2.71e-04 | 990 | 102 | 14 | JC_fibro_1000 |
| CoexpressionAtlas | dev gonad_e11.5_F_GonadVasMes_Flk_k-means-cluster#3_top-relative-expression-ranked_1000 | 3.10e-04 | 354 | 102 | 8 | gudmap_dev gonad_e11.5_F_GonadVasMes_Flk_k3_1000 | |
| CoexpressionAtlas | kidney_P0_JuxtaGlom_Ren1_top-relative-expression-ranked_500 | 3.52e-04 | 456 | 102 | 9 | gudmap_kidney_P0_JuxtaGlom_Ren1_500 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitTestis_Sma_top-relative-expression-ranked_500 | 3.53e-04 | 361 | 102 | 8 | gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_500 | |
| CoexpressionAtlas | JC_fibro_top-relative-expression-ranked_1000_k-means-cluster#1 | 4.00e-04 | 464 | 102 | 9 | JC_fibro_1000_K1 | |
| CoexpressionAtlas | ratio_induced-Ectoderm_vs_StemCell_top-relative-expression-ranked_500_k-means-cluster#1 | 4.00e-04 | 279 | 102 | 7 | ratio_ECTO_vs_SC_500_K1 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_k-means-cluster#2_top-relative-expression-ranked_1000 | 4.12e-04 | 130 | 102 | 5 | gudmap_developingKidney_e15.5_1000_k2 | |
| CoexpressionAtlas | kidney_P3_CapMes_Crym_top-relative-expression-ranked_500 | 4.16e-04 | 370 | 102 | 8 | gudmap_kidney_P3_CapMes_Crym_500 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_top-relative-expression-ranked_1000 | CLEC18A RELN SPINT1 ZSWIM5 XIAP ATAD2 TENM2 CELSR1 CELSR2 ADAMTS9 JAG1 LRP2 | 4.30e-04 | 795 | 102 | 12 | gudmap_developingKidney_e15.5_anlage of loop of Henle_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_top-relative-expression-ranked_1000 | AHCYL1 ADAMTS3 TNC LAMA3 XIAP ADAM10 TENM2 TENM4 TC2N CNTNAP4 TNFRSF19 MEGF10 | 4.86e-04 | 806 | 102 | 12 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_top-relative-expression-ranked_1000 | ADAMTS3 TNC LAMA3 XIAP ADAMTS5 TENM2 CELSR1 TENM4 CNTNAP4 ADAMTS20 TNFRSF19 MEGF10 | 4.86e-04 | 806 | 102 | 12 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_top-relative-expression-ranked_1000 | AHCYL1 ADAMTS3 XIAP THSD7B TENM2 CCN4 TENM4 CNTNAP4 ADAMTS20 TNFRSF19 LTBP1 MEGF10 | 5.54e-04 | 818 | 102 | 12 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000 |
| CoexpressionAtlas | ratio_induced-Ectoderm_vs_StemCell_top-relative-expression-ranked_500 | CLEC18A TMPRSS9 RELN CLEC18B CLEC18C SSPOP ADAMTS9 LRP2 LTBP2 | 6.36e-04 | 495 | 102 | 9 | PCBC_ratio_ECTO_vs_SC_500 |
| CoexpressionAtlas | ratio_induced-DefinitiveEndoderm_vs_StemCell_top-relative-expression-ranked_500 | 6.36e-04 | 495 | 102 | 9 | PCBC_ratio_DE_vs_SC_500 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Podocyte cells_emap-27915_top-relative-expression-ranked_1000 | CLEC18A NAIP LAMA2 ATAD2 ITGB2 TENM2 NELL1 CELSR1 CELSR2 JAG1 LTBP1 MEGF10 | 6.71e-04 | 836 | 102 | 12 | gudmap_developingKidney_e15.5_Podocyte cells_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_stage III -IV renal corpusc_emap-27945_top-relative-expression-ranked_1000 | CLEC18A RELN XIAP ADAMTS5 ITGB5 STAB1 TENM4 EGF IGFBP7 TRIM8 LRP2 LTBP1 | 6.78e-04 | 837 | 102 | 12 | gudmap_developingKidney_e15.5_stage III -IV renal corpusc_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k-means-cluster#4_top-relative-expression-ranked_1000 | 7.22e-04 | 147 | 102 | 5 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k4_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_1000 | ADAMTS3 TNC THSD7B ACSS2 TENM2 TDRD7 CCN4 NELL1 FBLN2 IGFBP7 SEMA5B LTBP1 LTBP3 | 7.32e-04 | 967 | 102 | 13 | Facebase_RNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Paraxial Mesoderm_top-relative-expression-ranked_1000 | ADAMTS3 TNC DGKB THSD7B ACSS2 TENM2 CCN4 NELL1 FBLN2 IGFBP7 SEMA5B LTBP1 LTBP3 | 7.32e-04 | 967 | 102 | 13 | Facebase_RNAseq_e8.5_Paraxial Mesoderm_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Maxillary Arch_top-relative-expression-ranked_1000 | ADAMTS3 TNC THSD7B ACSS2 TENM2 CCN4 NELL1 FBLN2 IGFBP7 SEMA5B ADAMTS9 LTBP1 LTBP3 | 7.32e-04 | 967 | 102 | 13 | Facebase_RNAseq_e9.5_Maxillary Arch_1000 |
| CoexpressionAtlas | DevelopingKidney_e12.5_renal vesicle_emap-27679_k-means-cluster#2_top-relative-expression-ranked_500 | 7.44e-04 | 148 | 102 | 5 | gudmap_developingKidney_e12.5_renal vesicle_500_k2 | |
| CoexpressionAtlas | kidney_P3_CapMes_Crym_k-means-cluster#2_top-relative-expression-ranked_500 | 7.44e-04 | 148 | 102 | 5 | gudmap_kidney_P3_CapMes_Crym_k2_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_2500_k-means-cluster#3 | 7.47e-04 | 310 | 102 | 7 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_2500_K3 | |
| CoexpressionAtlas | Stromal Cells, St.31-38-44-.SLN, CD45- gp38- CD31- CD44-, Lymph Node, avg-2 | 7.54e-04 | 85 | 102 | 4 | GSM777067_100 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_S-shaped body_emap-27855_top-relative-expression-ranked_500 | 7.64e-04 | 406 | 102 | 8 | gudmap_developingKidney_e15.5_S-shaped body_500 | |
| ToppCell | COVID-19-Heart-Fib_+_EC_+_Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | COL4A1 FN1 TNC LAMA2 ADAMTS5 SVEP1 TENM4 IGFBP7 ADAMTS9 LTBP1 LTBP2 | 6.97e-13 | 182 | 106 | 11 | fbd5e332df73bf7141c822fa67b76367dc962017 |
| ToppCell | COVID-19-Heart-Fib_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | COL4A1 FN1 TNC LAMA2 ADAMTS5 SVEP1 FBLN2 TENM4 IGFBP7 LTBP1 LTBP2 | 8.34e-13 | 185 | 106 | 11 | 8f95d8e591bf7379d13f5a0545b0cb49e2b1ab5d |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | COL4A1 FN1 LAMA2 PAPLN F10 CCN4 FBLN2 IGFBP7 TENM3 LTBP1 LTBP2 | 1.32e-12 | 193 | 106 | 11 | b05361ffe111a38cfa26eb86e4ae62c15ac99b7b |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.32e-11 | 184 | 106 | 10 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.32e-11 | 184 | 106 | 10 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.32e-11 | 184 | 106 | 10 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | Control-Fibroblasts-Intermediate_pathological_FB|Control / group, cell type (main and fine annotations) | 3.91e-11 | 194 | 106 | 10 | 03a269f75a481ea54aea8e6444605db8d6df493d | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.12e-11 | 195 | 106 | 10 | 1236dc60288c7dd91868e86e9174a2dacd3b11b3 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | COL4A1 FN1 LAMA2 SVEP1 IGFBP7 TENM3 ADGRE5 LTBP1 LTBP2 NOTCH3 | 4.33e-11 | 196 | 106 | 10 | fa445f4240c521cf04eb2e2f79a5c55fda31209a |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | COL4A1 FN1 LAMA2 SVEP1 IGFBP7 TENM3 ADGRE5 LTBP1 LTBP2 NOTCH3 | 4.33e-11 | 196 | 106 | 10 | 802f61e78a9a1030a86c4a980c398a73cd4d1574 |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.55e-11 | 197 | 106 | 10 | 9b480f9c799a244bfee64487abd8a1bf07c9a3a2 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.03e-11 | 199 | 106 | 10 | 0019cfaa586a450c2e4952d1184a540561c8d0ba | |
| ToppCell | (02)_MMP9/10+|World / shred by cell type by condition | 5.03e-11 | 199 | 106 | 10 | 3f78eddeaa67d3b767aa38de765632166b09a4f0 | |
| ToppCell | Bronchus_Control_(B.)-Stromal-TX-Fibroblasts-2,_SCARA5|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 5.28e-11 | 200 | 106 | 10 | 2022df85df94ab8cbb4e80e3fe9894c01051c5e0 | |
| ToppCell | Parenchymal-10x5prime-Stromal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 5.28e-11 | 200 | 106 | 10 | 2e525c0d9684e7a2275edb04e1addb6fc6a872e5 | |
| ToppCell | Bronchus_Control_(B.)-Stromal-TX|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 5.28e-11 | 200 | 106 | 10 | 69b41f5fb370aa8840a9ad7919d03ef1e57d1b5b | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | COL4A1 FN1 TNC LAMA2 ADAMTS5 CCN4 IGFBP7 CHRDL1 LTBP3 NOTCH3 | 5.28e-11 | 200 | 106 | 10 | 67dcbd86fbc79fd585d0793f979e4aac100326c9 |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_G2M|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.58e-10 | 178 | 106 | 9 | 9fc5688cf705a74398d24e10e0aab4758612e72b | |
| ToppCell | PND01-03-samps-Mesenchymal-Myofibroblast|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 5.57e-10 | 182 | 106 | 9 | 812dac35b9aa05be48258082e007f6c00e7b4dd8 | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating-Lymphatic_EC_differentiating_L.2.5.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.85e-10 | 183 | 106 | 9 | 4d16bfbadf2cd13008c35e23dd2b5b4ecf92ee11 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_Arw_fibro_(16)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 6.44e-10 | 185 | 106 | 9 | 7dcdc009c5681ee05dd18968f7e85c3403fe34af | |
| ToppCell | E17.5-Mesenchymal-mesenchymal_fibroblast-mesenchymal_alveolar_niche_cell|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 6.44e-10 | 185 | 106 | 9 | c85bba1210f1d389add3e40be9b96abac40cf8c1 | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.75e-10 | 186 | 106 | 9 | 40070d9cd20188ba49b32acfca9bc16256b38bf5 | |
| ToppCell | (0)_MSCs|World / Cell class and subclass of bone marrow stroma cells in homeostatis | 6.75e-10 | 186 | 106 | 9 | a832c1e0035bcd559722eccf262c145deb3494c7 | |
| ToppCell | (0)_MSCs-(00)_Lepr-MSC|World / Cell class and subclass of bone marrow stroma cells in homeostatis | 6.75e-10 | 186 | 106 | 9 | f0d156167d7cc2cd8a76e5a364233e9f2170bc01 | |
| ToppCell | COVID-19-Fibroblasts-Airway_smooth_muscle|COVID-19 / group, cell type (main and fine annotations) | 7.08e-10 | 187 | 106 | 9 | 464a0c3b92b778911b5f9cd73642e09e3472063a | |
| ToppCell | -Donor_07|World / lung cells shred on cell class, cell subclass, sample id | 7.42e-10 | 188 | 106 | 9 | 038f48e8daaeb72716e975d22a6b004a90654960 | |
| ToppCell | COVID-19-Heart-Fib_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 7.42e-10 | 188 | 106 | 9 | fe361215f4ba841aa5e1e581fb56f2f4d3ccd201 | |
| ToppCell | Mesenchymal-myofibroblast_cell|World / Lineage, Cell type, age group and donor | 7.78e-10 | 189 | 106 | 9 | 44e37f88137bb249933eb615235b2cf2ae7f3925 | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_osteo-stroma-osteochondral_precursor|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 7.78e-10 | 189 | 106 | 9 | 1ff4f8da572bdc6356e9df9f41a7f62c81d4c570 | |
| ToppCell | P03-Mesenchymal-developing_mesenchymal_cell-mesenchymal_myogenic_precursor_(Axin2+)|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 8.15e-10 | 190 | 106 | 9 | 979b1476fd2692fde977ce56257315fcfc8a01d5 | |
| ToppCell | E15.5-Mesenchymal-mesenchymal_fibroblast-mesenchymal_alveolar_niche_cell|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 8.54e-10 | 191 | 106 | 9 | 053b3664f509baa107feaf90730f80ebf9ac8f14 | |
| ToppCell | human_hepatoblastoma-Hepatic_Stellate_cells|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells) | 8.54e-10 | 191 | 106 | 9 | 78c3c2fdb68c3407f2436f90e1e6a780bbf8b79e | |
| ToppCell | Mesenchymal-vascular_smooth_muscle_cell|World / Lineage, Cell type, age group and donor | 8.54e-10 | 191 | 106 | 9 | fd89fbc62aa1c73e0f659991e3bd726a0c97bd68 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.94e-10 | 192 | 106 | 9 | df1545670370fb1010c567cd059c2783eab315f7 | |
| ToppCell | droplet-Limb_Muscle-nan-18m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.36e-10 | 193 | 106 | 9 | 45b5cab4dfeb0ed3b13631db5963740a792b810f | |
| ToppCell | COVID-19-Heart-Fib_2|Heart / Disease (COVID-19 only), tissue and cell type | 9.79e-10 | 194 | 106 | 9 | d91c9f2ec47319051fc398320693fddbe8bbd4d6 | |
| ToppCell | facs-Heart-RA-18m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.02e-09 | 195 | 106 | 9 | 690d6e15d7c863fc8f2d33b1f7bf86f019f415c9 | |
| ToppCell | COVID-19-Heart-Fib_1|Heart / Disease (COVID-19 only), tissue and cell type | 1.02e-09 | 195 | 106 | 9 | f423baa36ac7cdc383c033e35a7d17e6bf913323 | |
| ToppCell | facs-Heart-RA-18m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.02e-09 | 195 | 106 | 9 | 5c05e2bcea3d5d7ebe6325f7187ccf83301053d8 | |
| ToppCell | COPD-Stromal-Myofibroblast|COPD / Disease state, Lineage and Cell class | 1.07e-09 | 196 | 106 | 9 | af206bb5bbb8b604a6212acd79878bcc3d326cec | |
| ToppCell | COVID-19-Fibroblasts-Intermediate_pathological_FB|COVID-19 / group, cell type (main and fine annotations) | 1.12e-09 | 197 | 106 | 9 | f1c8936986123a3151140c374fcd62d6705c530b | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.12e-09 | 197 | 106 | 9 | 85a8f1d18e0dd1d31341f5131eecd217553bf042 | |
| ToppCell | COPD-Stromal-Myofibroblast|World / Disease state, Lineage and Cell class | 1.12e-09 | 197 | 106 | 9 | d51f484b4e01ac64233950d0b97fa88825ea1dbb | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.12e-09 | 197 | 106 | 9 | e8e3ba791dfaa0fab35e0329a5e34376f9ee6143 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.12e-09 | 197 | 106 | 9 | 71786e9432e2d649f5d86f639abb25e7102deb67 | |
| ToppCell | COPD-Stromal|COPD / Disease state, Lineage and Cell class | 1.12e-09 | 197 | 106 | 9 | d5390d86acaa8c39f1da893e8d2271f9ed2951d7 | |
| ToppCell | IPF-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 1.12e-09 | 197 | 106 | 9 | f304d42fc4936fe20996e07c8dccc698a6e5e5ef | |
| ToppCell | Fibroblasts|World / lung cells shred on cell class, cell subclass, sample id | 1.23e-09 | 199 | 106 | 9 | e2b6752fcabd5249a166486ae6796f2c97c1fcaf | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.23e-09 | 199 | 106 | 9 | 4e128c705ad36fd840582848f278770f356fcc8b | |
| ToppCell | COVID-19-kidney-Fibroblast-1|kidney / Disease (COVID-19 only), tissue and cell type | 1.23e-09 | 199 | 106 | 9 | 9503646ff1ad248181146ce767e9d12e882ec3bd | |
| ToppCell | cellseq-Mesenchymal|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.28e-09 | 200 | 106 | 9 | 238285fc372ce2e5e4341fc3084a3a833bf4a0a6 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Transitional_Stromal_3_(C3+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.28e-09 | 200 | 106 | 9 | cfea2f9d85646c9b722150551ff2e8fc4f6cc98a | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.28e-09 | 200 | 106 | 9 | ba5ed66b05caa1be0bbf8d54c4e72a782b8d9833 | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Mesenchymal|Transplant_Alveoli_and_parenchyma / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.28e-09 | 200 | 106 | 9 | 954fee8425673e76198be414f5f6c4e3597c1919 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.28e-09 | 200 | 106 | 9 | 2e4ab7fbd94d3d865ef6188d3b4916d2bf1b8d89 | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.28e-09 | 200 | 106 | 9 | f6be0f24e607abb9007823a54fb0b24d04990a89 | |
| ToppCell | Parenchyma_Control_(B.)-Stromal-TX|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 1.28e-09 | 200 | 106 | 9 | 0a86656d48e4238d0e4d592d477d29f7ba7c2ec0 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.28e-09 | 200 | 106 | 9 | 3fa7d9ea67f9cc55478d085da53babd03dbe9bb1 | |
| ToppCell | tumor_Lung-Fibroblasts|tumor_Lung / Location, Cell class and cell subclass | 1.28e-09 | 200 | 106 | 9 | 073a68b5ce232203ffee86342cba2a00d907e119 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.28e-09 | 200 | 106 | 9 | 1e75d1302c22e1b1666c19c0c9259d5cc8be16d5 | |
| ToppCell | Tracheal-10x5prime-Stromal-Fibroblastic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.28e-09 | 200 | 106 | 9 | 7ba292c30d915e66ebc8026fa76492cedf64700e | |
| ToppCell | Biopsy_Other_PF-Mesenchymal|Biopsy_Other_PF / Sample group, Lineage and Cell type | 1.28e-09 | 200 | 106 | 9 | d6fcdd48858b53b5a8d18ae14b2dc4d9af41b070 | |
| ToppCell | Parenchymal-10x5prime-Stromal-Fibroblastic-Fibro_myofibroblast|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.28e-09 | 200 | 106 | 9 | 54806080b5e97859ee6a4a9b4f19e22021c218f5 | |
| ToppCell | Tracheal-10x5prime-Stromal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.28e-09 | 200 | 106 | 9 | 920e6036c0a9c0089d0d898673daf9dd9d7279fc | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 7.75e-09 | 170 | 106 | 8 | fa753cc8fbd04e63c9a303da4dc17ee2ce907f92 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 7.75e-09 | 170 | 106 | 8 | 03044e1436443b28dd39d5ef4fdb25c18e3a7546 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_prolif|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.30e-09 | 174 | 106 | 8 | 778e0317c0c63fa4efd74114feb760975b819d92 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-vascular_smooth_muscle_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 9.30e-09 | 174 | 106 | 8 | 015d3742d3d79a57413a333f00ef2d380a9848dd | |
| ToppCell | Endothelial-B-SSc-ILD_02|World / lung cells shred on cell class, cell subclass, sample id | 1.02e-08 | 176 | 106 | 8 | b288116a4588a1f9db9d49af92cea118937c9201 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.02e-08 | 176 | 106 | 8 | 9bc87cd5cda2372e1bce94c9dfd408eb1dfd8d0c | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.02e-08 | 176 | 106 | 8 | 3f8274a7ab67f9f8a8923193763a5543cfe4defa | |
| ToppCell | 356C-Fibroblasts-Fibroblast-C_(Myofibroblast)-|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.06e-08 | 177 | 106 | 8 | cdfd2f0ee2f692271b1525e414b0f645cdadb1f6 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-C_(Myofibroblast)|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.06e-08 | 177 | 106 | 8 | db222faaecbe5600da39277243c4e7e764eb63c9 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-vascular_smooth_muscle_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.11e-08 | 178 | 106 | 8 | 066dbc4cc2083c549d98122ed44707127f34d582 | |
| ToppCell | E15.5-Mesenchymal-myocytic_cell-vascular_associated_smooth_muscle_cell|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.21e-08 | 180 | 106 | 8 | 38035cf2c6fbc443ea10ca7e942572715ed572da | |
| ToppCell | RA-07._Pericyte|RA / Chamber and Cluster_Paper | 1.27e-08 | 181 | 106 | 8 | 8dfb42d096db6c2df9b41303a7199d134d4bff07 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.27e-08 | 181 | 106 | 8 | b116c68393d8836bac080f81a8fcbeb52e0403e7 | |
| ToppCell | 5'-Adult-LymphNode-Mesenchymal-fibroblastic-Transitional_Stromal_3_(C3+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.27e-08 | 181 | 106 | 8 | ab66a89f316b935d9ba1277426d976b1e9e39757 | |
| ToppCell | RA-07._Pericyte|World / Chamber and Cluster_Paper | 1.32e-08 | 182 | 106 | 8 | 2075efeae633550fb2eb026d0dfd741c8252482e | |
| ToppCell | 5'-Adult-Appendix-Endothelial-lymphatic_endothelial-LEC6_(ADAMTS4+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.32e-08 | 182 | 106 | 8 | fd786c88826ad3d5cc5c3d80f8e392d6be1b5267 | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.32e-08 | 182 | 106 | 8 | d179b5deb07c20d49eb6c58d5a65904f8921de3a | |
| ToppCell | LA-07._Pericyte|World / Chamber and Cluster_Paper | 1.38e-08 | 183 | 106 | 8 | e3835db4795362b0442d5893baf2a78efcc20428 | |
| ToppCell | 5'-Adult-Appendix-Endothelial-lymphatic_endothelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.44e-08 | 184 | 106 | 8 | 453295362888c9a59d0e73c7a5b15914c50ff591 | |
| ToppCell | LA-07._Pericyte|LA / Chamber and Cluster_Paper | 1.50e-08 | 185 | 106 | 8 | ba5baa4d7f097108622674de5b7f4fd279843d24 | |
| ToppCell | human_hepatoblastoma-Hepatic_Stellate_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 1.57e-08 | 186 | 106 | 8 | cb1fc4b9140666b43415e21c9b434dc9b144e9d0 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.57e-08 | 186 | 106 | 8 | 5473283fb95cee556b1f6934cf72169b676b5bcc | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.57e-08 | 186 | 106 | 8 | 23b8d51d20b05795a73892d3e20e0f9b6a207820 | |
| ToppCell | E16.5-samps-Mesenchymal-Myofibroblast|E16.5-samps / Age Group, Lineage, Cell class and subclass | 1.57e-08 | 186 | 106 | 8 | e044b3428b7eacfdc72d0f57cdabaa1de04c74cd | |
| ToppCell | 5'-GW_trimst-2-LymphNode-Mesenchymal-Pericytes-angiogenic_pericyte|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.63e-08 | 187 | 106 | 8 | b8f88599e22b9b345c7ec3bbecd87a8b2a033f9f | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.63e-08 | 187 | 106 | 8 | c104fbfef2d0bef64077ac721edf2379fd59d547 | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.77e-08 | 189 | 106 | 8 | 45e588b2a4ad9e3ff74e22d9d627ed3571f3b8b8 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.85e-08 | 190 | 106 | 8 | 1121eb607a984c59fbffe7220837fc178745aa55 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.85e-08 | 190 | 106 | 8 | 048b581e3f7ea9fc2f87c0532974bba85c7292c2 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.85e-08 | 190 | 106 | 8 | 70c86dd454afb21d4a85db56c5f369d4b342bc97 | |
| ToppCell | Control-Fibroblasts|Control / group, cell type (main and fine annotations) | 1.85e-08 | 190 | 106 | 8 | 3a42a9b98d954685d38a741f44545898d0e3e9ce | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.85e-08 | 190 | 106 | 8 | 10b02c62e72bfea9767e3e751011436925da823e | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.92e-08 | 191 | 106 | 8 | 9431ffd6b758f756609d9057de2023596e22b5d4 | |
| ToppCell | Control-Stromal_mesenchymal|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.92e-08 | 191 | 106 | 8 | 14057205ddb9b4bbc582d1358d13cf36d979a61b | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.92e-08 | 191 | 106 | 8 | 4b50fdd310701251e64e16cd2d07ce03dbfd3e3e | |
| Computational | Adhesion molecules. | 1.00e-07 | 141 | 62 | 9 | MODULE_122 | |
| Computational | ECM and collagens. | 5.49e-07 | 225 | 62 | 10 | MODULE_47 | |
| Computational | Genes in the cancer module 412. | 6.90e-07 | 13 | 62 | 4 | MODULE_412 | |
| Computational | Genes in the cancer module 275. | 1.73e-06 | 16 | 62 | 4 | MODULE_275 | |
| Computational | DRG (dorsal root ganglia) genes. | 6.15e-05 | 384 | 62 | 10 | MODULE_2 | |
| Computational | Metal / Ca ion binding. | 1.12e-04 | 133 | 62 | 6 | MODULE_324 | |
| Computational | Lung genes. | 1.69e-04 | 434 | 62 | 10 | MODULE_5 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 1.89e-04 | 50 | 62 | 4 | GAVISH_3CA_METAPROGRAM_FIBROBLASTS_PERICYTE_LIKE | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 1.89e-04 | 50 | 62 | 4 | GAVISH_3CA_MALIGNANT_METAPROGRAM_13_EMT_2 | |
| Computational | Placenta genes. | 2.86e-04 | 463 | 62 | 10 | MODULE_38 | |
| Computational | Developmental processes. | 6.13e-04 | 333 | 62 | 8 | MODULE_220 | |
| Computational | Ovary genes. | 1.17e-03 | 368 | 62 | 8 | MODULE_1 | |
| Drug | pyrachlostrobin | COL4A1 FN1 TNC ITGB2 ITGB5 SVEP1 STAB1 CCN4 CELSR1 FBLN2 IGFBP7 ADAMTS9 CNTNAP4 LRP2 ADGRE5 LTBP1 LTBP2 LTBP3 MEGF10 NOTCH2 NOTCH3 | 1.13e-10 | 811 | 105 | 21 | ctd:C513428 |
| Drug | Rgd Peptide | 1.42e-08 | 239 | 105 | 11 | CID000104802 | |
| Drug | chondroitin sulfate | COL4A1 FN1 ADAMTS3 TNC LAMA3 ADAMTS5 FBLN2 EGF SEMA5B ADAMTS9 ADGRE5 LTBP1 | 4.62e-07 | 413 | 105 | 12 | CID000024766 |
| Drug | Leu-asp-val | 1.95e-06 | 20 | 105 | 4 | CID000130816 | |
| Drug | Grgds | 2.36e-06 | 83 | 105 | 6 | CID000123811 | |
| Drug | Sikvav | 4.23e-06 | 24 | 105 | 4 | CID005487517 | |
| Drug | kalinin | 5.49e-06 | 55 | 105 | 5 | CID000032518 | |
| Drug | rhamnose | 5.96e-06 | 356 | 105 | 10 | CID000000840 | |
| Drug | AC1L1B58 | 9.28e-06 | 29 | 105 | 4 | CID000001288 | |
| Drug | AC1L1G72 | 1.53e-05 | 11 | 105 | 3 | CID000003553 | |
| Drug | GDP-fucose | 1.57e-05 | 68 | 105 | 5 | CID000000451 | |
| Drug | MDL-28842 | 2.03e-05 | 12 | 105 | 3 | CID006441200 | |
| Drug | Fluor | 2.53e-05 | 75 | 105 | 5 | CID000024524 | |
| Drug | 2,3-pentanedione | 2.99e-05 | 129 | 105 | 6 | ctd:C013186 | |
| Drug | enzacamene | 2.99e-05 | 129 | 105 | 6 | ctd:C038939 | |
| Drug | GSK-3 Inhibitor IX; Up 200; 0.5uM; PC3; HT_HG-U133A | 3.40e-05 | 195 | 105 | 7 | 7106_UP | |
| Drug | Tranylcypromine hydrochloride [1986-47-6]; Up 200; 23.6uM; PC3; HT_HG-U133A | 3.75e-05 | 198 | 105 | 7 | 7293_UP | |
| Drug | Disulfiram [97-77-8]; Down 200; 13.4uM; PC3; HT_HG-U133A | 3.75e-05 | 198 | 105 | 7 | 5729_DN | |
| Drug | 2-[(1R,2R,3S,4R,5R,6S)-2-[(2R,5S)-3-[(3S,4S,5R,6S)-4,5-dihydroxy-3-(methylamino)-6-methylol-tetrahydropyran-2-yl]-4-formyl-4-hydroxy-5-methylol-tetrahydrofuran-2-yl]oxy-5-guanidino-3,4,6-trihydroxy-cyclohexyl]guanidine | 4.14e-05 | 83 | 105 | 5 | CID011968896 | |
| Drug | anad | 4.17e-05 | 15 | 105 | 3 | CID005287574 | |
| Drug | AC1L1G2K | 4.38e-05 | 84 | 105 | 5 | CID000003498 | |
| Drug | lead stearate | 4.38e-05 | 84 | 105 | 5 | CID000061258 | |
| Drug | octylmethoxycinnamate | 4.55e-05 | 139 | 105 | 6 | ctd:C118580 | |
| Drug | 1,2-dimethylhydrazine | 4.91e-05 | 86 | 105 | 5 | CID000001322 | |
| Drug | mono-(2-ethylhexyl)phthalate | STAB2 ZAN DGKB ITGB3 F10 DNAH14 ACSL1 FBLN2 EGF CELSR2 ADAMTS20 LTBP1 | 5.16e-05 | 658 | 105 | 12 | ctd:C016599 |
| Drug | LMWH | COL4A1 LAMB4 FN1 TNC LAMA2 LAMA3 F10 ACTL7A FBLN2 EGF IGFBP7 LRP2 | 5.55e-05 | 663 | 105 | 12 | CID000000772 |
| Drug | N6-hydroxyadenosine | 6.30e-05 | 3 | 105 | 2 | CID000018881 | |
| Drug | Cilengitide | 6.30e-05 | 3 | 105 | 2 | ctd:C422910 | |
| Drug | AC1L1KMJ | 7.11e-05 | 476 | 105 | 10 | CID000030956 | |
| Drug | colchine | 7.12e-05 | 383 | 105 | 9 | CID000002833 | |
| Drug | oxypertine | 7.71e-05 | 49 | 105 | 4 | CID000004640 | |
| Drug | Verteporfin [129497-78-5]; Down 200; 2.8uM; MCF7; HT_HG-U133A | 8.35e-05 | 155 | 105 | 6 | 6817_DN | |
| Drug | rebamipide | 9.03e-05 | 51 | 105 | 4 | CID000005042 | |
| Drug | Smoke | FN1 ADAMTS3 SPINT1 TNC SVEP1 CELSR1 TC2N EGF IGFBP7 SQSTM1 TRIM8 DLK2 LTBP1 NOTCH3 | 1.02e-04 | 937 | 105 | 14 | ctd:D012906 |
| Drug | Verteporfin [129497-78-5]; Down 200; 2.8uM; MCF7; HT_HG-U133A | 1.03e-04 | 161 | 105 | 6 | 3556_DN | |
| Drug | 1-(5-isoquinolinesulfonyl)-2-methylpiperazine | 1.05e-04 | 314 | 105 | 8 | CID000003542 | |
| Drug | gamma-secretase inhibitor I | 1.26e-04 | 4 | 105 | 2 | CID011754711 | |
| Drug | Rgds Peptide | 1.33e-04 | 106 | 105 | 5 | CID000107775 | |
| Drug | R-Te | 1.40e-04 | 57 | 105 | 4 | CID000068913 | |
| Disease | Glioblastoma | 3.14e-07 | 79 | 101 | 6 | C0017636 | |
| Disease | Giant Cell Glioblastoma | 4.53e-07 | 84 | 101 | 6 | C0334588 | |
| Disease | cortical surface area measurement | SPRY2 RELN RAPSN ZAN ADAMTS3 OR5B12 LAMA2 TENM2 ITGB5 SVEP1 NELL1 CELSR1 ADAMTS9 JAG1 TRIM8 ADAMTS20 BRD1 FBN3 | 6.60e-07 | 1345 | 101 | 18 | EFO_0010736 |
| Disease | autosomal recessive intellectual developmental disorder (implicated_via_orthology) | 2.15e-06 | 8 | 101 | 3 | DOID:0060308 (implicated_via_orthology) | |
| Disease | Glioblastoma Multiforme | 2.34e-06 | 111 | 101 | 6 | C1621958 | |
| Disease | pulse pressure measurement | COL4A1 TRAF7 FLOT2 RAPSN FN1 CLEC18C SSPOP ITGB5 SVEP1 TENM4 JAG1 TRIM8 LTBP1 LTBP2 LTBP3 BRD1 NOTCH3 | 4.80e-06 | 1392 | 101 | 17 | EFO_0005763 |
| Disease | Hepatic ductular hypoplasia | 1.16e-05 | 2 | 101 | 2 | C2930797 | |
| Disease | Alagille syndrome (is_implicated_in) | 1.16e-05 | 2 | 101 | 2 | DOID:9245 (is_implicated_in) | |
| Disease | Alagille Syndrome 2 | 1.16e-05 | 2 | 101 | 2 | C1857761 | |
| Disease | Alagille Syndrome 1 | 1.16e-05 | 2 | 101 | 2 | C1956125 | |
| Disease | Alagille Syndrome | 1.16e-05 | 2 | 101 | 2 | C0085280 | |
| Disease | Arteriohepatic dysplasia | 1.16e-05 | 2 | 101 | 2 | cv:C0085280 | |
| Disease | anthropometric measurement | 2.52e-05 | 168 | 101 | 6 | EFO_0004302 | |
| Disease | cortical thickness | FLOT2 RELN RAPSN ADAMTS3 LAMA2 ADAM10 TENM2 ITGB5 STAB1 NELL1 CELSR1 ADAMTS9 JAG1 ADAMTS20 | 2.62e-05 | 1113 | 101 | 14 | EFO_0004840 |
| Disease | Skin Ulcer | 6.93e-05 | 4 | 101 | 2 | C0037299 | |
| Disease | Malignant neoplasm of breast | FN1 ZSWIM5 LAMA2 TECTA TTC3 ADAM10 EGF IGFBP7 SEMA5B ANKEF1 JAG1 NOTCH2 NOTCH3 | 7.70e-05 | 1074 | 101 | 13 | C0006142 |
| Disease | serum IgG glycosylation measurement | 7.94e-05 | 523 | 101 | 9 | EFO_0005193 | |
| Disease | scoliosis (implicated_via_orthology) | 1.15e-04 | 5 | 101 | 2 | DOID:0060249 (implicated_via_orthology) | |
| Disease | lymphocyte count | COL4A1 RAPSN ZAN FN1 CLEC18C ITGB2 IFIH1 TENM4 EGF SQSTM1 JAG1 ADGRE5 LTBP2 LTBP3 NOTCH2 | 1.35e-04 | 1464 | 101 | 15 | EFO_0004587 |
| Disease | Myopathy | 1.48e-04 | 30 | 101 | 3 | C0026848 | |
| Disease | Congenital cataract | 1.72e-04 | 6 | 101 | 2 | C0009691 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 1.81e-04 | 152 | 101 | 5 | DOID:0060041 (implicated_via_orthology) | |
| Disease | Schizophrenia | RELN ADAMTS3 LAMA2 ITGB3 TENM4 JAG1 LRP2 CSMD1 BRD1 FUT8 MEGF10 | 2.22e-04 | 883 | 101 | 11 | C0036341 |
| Disease | osteoarthritis (is_marker_for) | 2.35e-04 | 35 | 101 | 3 | DOID:8398 (is_marker_for) | |
| Disease | adenocarcinoma (implicated_via_orthology) | 2.41e-04 | 7 | 101 | 2 | DOID:299 (implicated_via_orthology) | |
| Disease | psoriasis (implicated_via_orthology) | 2.41e-04 | 7 | 101 | 2 | DOID:8893 (implicated_via_orthology) | |
| Disease | cholesteryl ester 16:2 measurement | 2.41e-04 | 7 | 101 | 2 | EFO_0021435 | |
| Disease | central nervous system cancer (implicated_via_orthology) | 2.41e-04 | 7 | 101 | 2 | DOID:3620 (implicated_via_orthology) | |
| Disease | Drugs used in diabetes use measurement | 2.51e-04 | 255 | 101 | 6 | EFO_0009924 | |
| Disease | Stevens-Johnson syndrome, toxic epidermal necrolysis, response to cold medicine | 2.78e-04 | 37 | 101 | 3 | EFO_0004276, EFO_0004775, EFO_0006997 | |
| Disease | waist-hip ratio | COL4A1 RAPSN FN1 DGKB ITGB3 STAB1 TDRD7 NELL1 ADAMTS9 TRIM8 ADAMTS20 LTBP2 LTBP3 | 2.83e-04 | 1226 | 101 | 13 | EFO_0004343 |
| Disease | neuroimaging measurement | CLEC18A RELN RAPSN ADAMTS3 LAMA2 ITGB5 CCN4 NELL1 RHOQ CELSR1 JAG1 ADAMTS20 | 2.95e-04 | 1069 | 101 | 12 | EFO_0004346 |
| Disease | serum gamma-glutamyl transferase measurement | COL4A1 OR5B12 ZSWIM5 ASH1L ITGB2 TENM2 STAB1 TENM4 CELSR2 CSMD1 NOTCH2 | 2.98e-04 | 914 | 101 | 11 | EFO_0004532 |
| Disease | phosphatidylcholine 32:1 measurement | 3.01e-04 | 38 | 101 | 3 | EFO_0010373 | |
| Disease | COVID-19, mortality | 3.03e-04 | 170 | 101 | 5 | EFO_0004352, MONDO_0100096 | |
| Disease | factor VIII measurement | 3.51e-04 | 40 | 101 | 3 | EFO_0004630 | |
| Disease | bringing up phlegm, sputum or mucus on most days, self-reported | 4.11e-04 | 9 | 101 | 2 | EFO_0009824 | |
| Disease | Glaucoma | 4.11e-04 | 9 | 101 | 2 | C0017601 | |
| Disease | Mammary Carcinoma, Human | 4.53e-04 | 525 | 101 | 8 | C4704874 | |
| Disease | Mammary Neoplasms, Human | 4.53e-04 | 525 | 101 | 8 | C1257931 | |
| Disease | Mammary Neoplasms | 4.64e-04 | 527 | 101 | 8 | C1458155 | |
| Disease | Bone Diseases | 5.13e-04 | 10 | 101 | 2 | C0005940 | |
| Disease | allergic rhinitis (biomarker_via_orthology) | 5.13e-04 | 10 | 101 | 2 | DOID:4481 (biomarker_via_orthology) | |
| Disease | open-angle glaucoma | 5.17e-04 | 191 | 101 | 5 | EFO_0004190 | |
| Disease | Breast Carcinoma | 5.32e-04 | 538 | 101 | 8 | C0678222 | |
| Disease | amino acid measurement | 5.40e-04 | 678 | 101 | 9 | EFO_0005134 | |
| Disease | pneumococcal bacteremia | 6.25e-04 | 11 | 101 | 2 | EFO_1001925 | |
| Disease | free cholesterol to total lipids in small HDL percentage | 7.19e-04 | 51 | 101 | 3 | EFO_0022285 | |
| Disease | von Willebrand factor measurement, coronary artery disease | 7.36e-04 | 118 | 101 | 4 | EFO_0001645, EFO_0004629 | |
| Disease | Mitral valve prolapse, response to surgery | 7.49e-04 | 12 | 101 | 2 | EFO_0009951, HP_0001634 | |
| Disease | stenosing tenosynovitis | 7.49e-04 | 12 | 101 | 2 | EFO_0010822 | |
| Disease | phosphocreatine measurement | 8.83e-04 | 13 | 101 | 2 | EFO_0010521 | |
| Disease | Migraine Disorders | 8.83e-04 | 13 | 101 | 2 | C0149931 | |
| Disease | FVC change measurement, response to placebo | 8.83e-04 | 13 | 101 | 2 | EFO_0008344, EFO_0010339 | |
| Disease | severe acute respiratory syndrome, COVID-19 | 8.84e-04 | 447 | 101 | 7 | EFO_0000694, MONDO_0100096 | |
| Disease | Seizures | 9.37e-04 | 218 | 101 | 5 | C0036572 | |
| Disease | Impaired cognition | 1.03e-03 | 14 | 101 | 2 | C0338656 | |
| Disease | level of Phosphatidylethanolamine (18:1_18:1) in blood serum | 1.03e-03 | 14 | 101 | 2 | OBA_2045142 | |
| Disease | esterified cholesterol measurement, low density lipoprotein cholesterol measurement | 1.03e-03 | 14 | 101 | 2 | EFO_0004611, EFO_0008589 | |
| Disease | body weight | COL4A1 RELN RAPSN ADAMTS3 THSD7B DNAH14 NELL1 CNTNAP4 CHRDL1 LTBP1 LTBP2 LTBP3 | 1.26e-03 | 1261 | 101 | 12 | EFO_0004338 |
| Disease | Cerebrovascular accident | 1.27e-03 | 62 | 101 | 3 | C0038454 | |
| Disease | phosphatidylcholine 38:6 measurement | 1.35e-03 | 16 | 101 | 2 | EFO_0010388 | |
| Disease | Dermatitis | 1.35e-03 | 16 | 101 | 2 | C0011603 | |
| Disease | Liver Cirrhosis, Experimental | 1.37e-03 | 774 | 101 | 9 | C0023893 | |
| Disease | type 1 diabetes mellitus | 1.49e-03 | 242 | 101 | 5 | MONDO_0005147 | |
| Disease | Dementia | 1.53e-03 | 17 | 101 | 2 | C0497327 | |
| Disease | Eye Abnormalities | 1.53e-03 | 17 | 101 | 2 | C0015393 | |
| Disease | interstitial lung disease | 1.59e-03 | 67 | 101 | 3 | EFO_0004244 | |
| Disease | Child Behaviour Checklist assessment | 1.71e-03 | 18 | 101 | 2 | EFO_0005661 | |
| Disease | total cholesterol measurement, hematocrit, stroke, ventricular rate measurement, body mass index, atrial fibrillation, high density lipoprotein cholesterol measurement, coronary artery disease, diastolic blood pressure, triglyceride measurement, systolic blood pressure, heart failure, diabetes mellitus, glucose measurement, mortality, cancer | 1.73e-03 | 69 | 101 | 3 | EFO_0000275, EFO_0000400, EFO_0000712, EFO_0001645, EFO_0003144, EFO_0004340, EFO_0004348, EFO_0004352, EFO_0004468, EFO_0004530, EFO_0004574, EFO_0004612, EFO_0006335, EFO_0006336, EFO_0007928, MONDO_0004992 | |
| Disease | intraocular pressure measurement | 1.86e-03 | 509 | 101 | 7 | EFO_0004695 | |
| Disease | glomerulonephritis (is_marker_for) | 1.91e-03 | 19 | 101 | 2 | DOID:2921 (is_marker_for) | |
| Disease | level of Phosphatidylethanolamine (18:0_20:4) in blood serum | 1.91e-03 | 19 | 101 | 2 | OBA_2045140 | |
| Disease | level of Sphingomyelin (d38:2) in blood serum | 1.91e-03 | 19 | 101 | 2 | OBA_2045179 | |
| Disease | sodium-coupled monocarboxylate transporter 1 measurement | 1.91e-03 | 19 | 101 | 2 | EFO_0802076 | |
| Disease | glaucoma | 1.97e-03 | 154 | 101 | 4 | MONDO_0005041 | |
| Disease | hemoglobin A1 measurement | 2.10e-03 | 520 | 101 | 7 | EFO_0007629 | |
| Disease | juvenile idiopathic arthritis | 2.12e-03 | 74 | 101 | 3 | EFO_0002609 | |
| Disease | glomerulonephritis (biomarker_via_orthology) | 2.12e-03 | 20 | 101 | 2 | DOID:2921 (biomarker_via_orthology) | |
| Disease | pantothenic acid mesurement | 2.12e-03 | 20 | 101 | 2 | EFO_0010519 | |
| Disease | Osteoarthritis of hip | 2.12e-03 | 20 | 101 | 2 | C0029410 | |
| Disease | cancer (implicated_via_orthology) | 2.32e-03 | 268 | 101 | 5 | DOID:162 (implicated_via_orthology) | |
| Disease | lung cancer | 2.33e-03 | 21 | 101 | 2 | MONDO_0008903 | |
| Disease | Manic | 2.46e-03 | 78 | 101 | 3 | C0338831 | |
| Disease | glomerular filtration rate, renal transplant outcome measurement, donor genotype effect measurement | 2.56e-03 | 22 | 101 | 2 | EFO_0005199, EFO_0005208, EFO_0007892 | |
| Disease | otosclerosis | 2.74e-03 | 81 | 101 | 3 | EFO_0004213 | |
| Disease | level of Sphingomyelin (d40:2) in blood serum | 2.80e-03 | 23 | 101 | 2 | OBA_2045181 | |
| Disease | brain measurement, neuroimaging measurement | 2.87e-03 | 550 | 101 | 7 | EFO_0004346, EFO_0004464 | |
| Disease | periodontal measurement | 3.05e-03 | 24 | 101 | 2 | EFO_0007780 | |
| Disease | level of Phosphatidylethanolamine (16:0_18:2) in blood serum | 3.05e-03 | 24 | 101 | 2 | OBA_2045136 | |
| Disease | Carcinoma, Pancreatic Ductal | 3.05e-03 | 24 | 101 | 2 | C0887833 | |
| Disease | alpha-linolenic acid measurement | 3.31e-03 | 25 | 101 | 2 | EFO_0007759 | |
| Disease | migraine disorder, diastolic blood pressure | 3.31e-03 | 25 | 101 | 2 | EFO_0006336, MONDO_0005277 | |
| Disease | vital capacity | FN1 ADAMTS3 LAMA2 TENM2 SVEP1 LRP2 LTBP1 LTBP2 LTBP3 FBN3 ADAP2 | 3.38e-03 | 1236 | 101 | 11 | EFO_0004312 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| KQDTVQCFSCGGCLG | 191 | Q13075 | |
| YTGIKDIVQCFSCGG | 306 | Q13075 | |
| EGGTCALIKTECCVY | 391 | P60509 | |
| TCYLCKQKGVGACIQ | 326 | O95696 | |
| VGTCCVLDLYTYCKG | 2756 | Q9NR48 | |
| KCTCGLEGNCIDSQY | 721 | Q9BZ76 | |
| CDALCGGYIQGKSGT | 926 | Q96PZ7 | |
| VCINGQCAGSICEKY | 561 | O14672 | |
| QCAGSICEKYGLEEC | 566 | O14672 | |
| EGYGQTECTAGCCLT | 456 | P33121 | |
| CGVCGGDNSSCTKIV | 721 | Q9UNA0 | |
| EALVVSGGCCGSDYK | 11 | Q14254 | |
| GTCVNTLGSYTCQCL | 131 | P48960 | |
| KCTCGLEGNCIDSQY | 721 | Q9C0A0 | |
| GGFADCCKYIAQRGC | 261 | Q9NU02 | |
| GGVCAVINKSCCVYV | 396 | B6SEH9 | |
| CVGYCGADIKSICAE | 631 | Q6PL18 | |
| KYNCTCIDGAVGCTP | 141 | O95388 | |
| CVCDKGYLGINCVDA | 1896 | Q9NYQ6 | |
| GTCVNLLVGGFKCDC | 1341 | Q9HCU4 | |
| VKGECLYCFVTLCDG | 606 | Q9NR19 | |
| CGNGTCKNIIGSYNC | 1856 | Q75N90 | |
| KIDKCGVCGGDNSSC | 706 | P59510 | |
| ASYKLGIFICLNCCG | 36 | Q9NPF8 | |
| GQKGESCLICDIDGY | 461 | P02462 | |
| VAGCELCQGKGFICE | 591 | Q9H714 | |
| LYCGLCGESIGEKNS | 361 | Q13702 | |
| EVGCYKICSCGQSGL | 551 | O95980 | |
| AVGCCGLQLYKFGET | 116 | Q9H2P9 | |
| YGVLCAETCQCVNGG | 316 | Q96KG7 | |
| CVNGGKCYHVSGACL | 326 | Q96KG7 | |
| GTYGINCSSRCGCKN | 446 | Q96KG7 | |
| CTQLVAGSYFCGCIS | 166 | Q8NGE7 | |
| HGNCTGGLSGYKCLC | 731 | Q04721 | |
| SCKAGYTGTQCERCA | 1756 | Q16787 | |
| QGGLCAALGESCCFY | 516 | P61550 | |
| ACGTVGKQCCLYINY | 436 | Q9H9K5 | |
| GISLYKQCCDCCGLG | 511 | P98095 | |
| VGKQTTYTECCCLYG | 1541 | Q14766 | |
| GGVCKDRVNGFSCTC | 481 | Q9UM47 | |
| TGYPDCKACNCSGLG | 461 | P24043 | |
| CRNTKGSYECVCADG | 4021 | P98164 | |
| TGCVPVSKCACVYNG | 386 | P98088 | |
| GVSGVCVCKSRYPVC | 106 | Q16270 | |
| TNVCACLAIGSYICG | 136 | Q96R08 | |
| GVTYNCTCGCSVGLE | 456 | P18084 | |
| SCTCKPGYVGNGTIC | 501 | Q92832 | |
| EGCRYGGTCVAPNKC | 521 | Q92832 | |
| SCINGTKCICDPGYS | 2141 | P78509 | |
| ECGICRCDTGYIGKN | 466 | P05107 | |
| RCDTGYIGKNCECQT | 471 | P05107 | |
| YSICVRGECVKVGCD | 676 | O15072 | |
| KCGVCGGDNSSCKTV | 741 | Q9P2N4 | |
| GTECLCVCQSGTYGE | 536 | P13671 | |
| SCSEGNVYCGLKTCP | 146 | Q9BU40 | |
| SKCINTEGGYVCRCS | 886 | P01133 | |
| CTCYGGSRGFNCESK | 76 | P02751 | |
| KEYLGAICSCTCFGG | 2401 | P02751 | |
| RYEIGCLSGKLCCAN | 41 | Q7Z7B8 | |
| CADYQINGEIICKCG | 951 | Q9BYX4 | |
| IGVGKQGLCCSFCKY | 266 | Q9Y6T7 | |
| GCGKKTCATLACYLT | 2016 | Q0VDD8 | |
| CLGGECKNTVGSYQC | 1146 | Q14767 | |
| GACKNLQGSYVCVCD | 881 | Q9NS15 | |
| NYEGKGSLAGSVGCC | 851 | Q08554 | |
| KCECGSCVCIQPGSY | 606 | P05106 | |
| VICNCLQGYTGTQCG | 936 | A4D0S4 | |
| CKLGYGGKRCSECQE | 1101 | A4D0S4 | |
| CLCPSGYGGKTCELV | 236 | Q6UY11 | |
| CKDGLGEYTCTCLEG | 101 | P00742 | |
| KCTCGLEGNCIDSQY | 721 | Q96NU0 | |
| GGTCQDLVNGFKCVC | 386 | P78504 | |
| GGTCIDGVNSYKCIC | 641 | P78504 | |
| VCNINKGCGYGCQLH | 211 | Q9BYC5 | |
| GACCYVECSALTQKG | 156 | P17081 | |
| VVCGYGEVGKGCCAA | 396 | Q96HN2 | |
| CYCPKGLLEQAGGCI | 4461 | A2VEC9 | |
| IKSCCGGCFYGETEK | 6 | Q8N9U0 | |
| VCGYGEVGKGCCAAL | 316 | O43865 | |
| CIDGNCVCSAGYKGE | 651 | Q9NT68 | |
| ICSDGTLYCQVPCKG | 661 | Q8NHU6 | |
| VCLCPLGYTGLKCET | 1216 | Q4LDE5 | |
| KGICVDGVAGYRCTC | 1281 | Q4LDE5 | |
| NVIDYGTCVCCVKGL | 211 | O43597 | |
| CNGPVVGTRYKCSVC | 131 | Q13501 | |
| AVVVDLGTGYCKCGF | 71 | Q9Y615 | |
| VCDIGYGGAQCATKV | 281 | A5D8T8 | |
| VCDIGYGGAQCATKV | 281 | Q6UXF7 | |
| VCDIGYGGAQCATKV | 281 | Q8NCF0 | |
| CAECGKAFVRCSGLY | 301 | Q96EG3 | |
| GCQCDEGYALLGSQC | 1016 | O75443 | |
| CKPGYIGSNCQTALC | 1316 | Q8N2E2 | |
| CRCGECGKAFSQGSY | 106 | Q6ZNH5 | |
| TSVTCGCGNKDIFYC | 231 | Q9P217 | |
| YTGIGDQVQCFCCGG | 191 | P98170 | |
| KCLRCGGDGTTCYPV | 171 | O95428 | |
| TEQICKSFVYGGCLG | 271 | O43278 | |
| VGLTGFECRCGNVYC | 156 | Q6FIF0 | |
| CVNGVCICFEGYAGA | 231 | P24821 | |
| CIQGCKLYSGSADCT | 446 | Q6Q0C0 | |
| VCAGYLDGKVDSCQG | 371 | Q7Z410 | |
| SEGLDCLAYCGIGKV | 571 | P53804 | |
| CITGTCICNPGYKGE | 641 | Q6N022 | |
| LCSYVGPGQSRCTCK | 921 | Q9NY15 | |
| RCTCKLGFAGDGYQC | 931 | Q9NY15 | |
| CVCYGIGNFATCIVA | 141 | Q9UH36 | |
| TECICQKGYVGDGLT | 346 | Q8WWQ8 | |
| SCICKAGYEGDGTLC | 851 | Q8WWQ8 | |
| CKCAAGFQGNGTICT | 1456 | Q8WWQ8 | |
| TCTCKPNYIGDGFTC | 1581 | Q8WWQ8 | |
| NCTCKVGYVGDGFSC | 2296 | Q8WWQ8 | |
| GICIMGSCACNSGYK | 591 | Q9P273 | |
| GSCACNSGYKGESCE | 596 | Q9P273 | |
| NGNSCLGCGVEFKTC | 751 | Q9P283 | |
| LCQYSLGCGLTCGLS | 126 | A0PJX8 | |
| ECDGSGQGLYDKTIC | 216 | Q5TYW1 | |
| CEECGKGFICSSNLY | 421 | Q9NYT6 | |
| CCEQCGEYLPSKGAG | 466 | Q9UBW7 | |
| GYLSCKVTCESGDCR | 21 | Q9NS68 | |
| ECTVCGKAFSYCGSL | 471 | Q96NI8 | |
| FSYCTQGGVCGCEKG | 1481 | Q9C0I4 | |
| CEKYCGTKVGCTNIA | 351 | P13866 | |
| GGRKILVCSVDNCYC | 461 | Q9BZR9 | |
| SGCTEKCVCTGGAIQ | 2286 | Q9Y493 |